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ABSTRACT 
 
During the development of the nervous system, neurons migrate to their final location 
and extend neurites that navigate long distances in the extracellular environment to reach their 
synaptic targets. The proper functioning of the nervous system depends on correct connectivity, 
and mistakes in the wiring of the nervous system lead to brain abnormalities and mental illness. 
Growth cones are motile structures located at the tip of extending neurites that sense and respond 
to guidance cues encountered along the path toward their targets. Binding of these cues to 
receptors located on growth cone filopodia and lamellipodia triggers intracellular signaling 
pathways that regulate growth cone cytoskeletal dynamics. Although studies on extracellular 
cues and their effects on neuronal guidance are well documented, less is known about the 
intracellular signaling mechanisms that regulate growth cone motility. This dissertation focuses 
on two signaling pathways and describes how they might be involved in determining growth 
cone morphology during neuronal development. The specific aims of this work address: (1) the 
role of phosphatidylinositol-3-kinase (PI-3K) and its downstream signaling pathway in 
regulating growth cone motility, and (2) the effect of nitric oxide (NO) release from a single cell 
on growth cone morphology of neighboring neurons. 
This study employs defined neurons from the pond snail, Helisoma trivolvis, to 
demonstrate that inhibition of PI-3K induces a concomitant increase in filopodial length and a 
decrease in the rate at which neurites advance. These effects are mediated through the lipid and 
protein kinase activities of PI-3K, and filopodial elongation is due to an increase in the rate at 
which filopodia elongate and the time that individual filopodia spend extending. Additionally, 
this study demonstrates that NO release from a single cell can affect growth cone dynamics on 
neighboring neurons via soluble guanylyl cyclase (sGC), and that NO has a physiological effect 
up to a distance of 100 µm. Overall this study provides new information on cellular mechanisms 
regulating growth cone motility, and suggests a potential role of PI-3K and NO in neuronal 
pathfinding in vivo. 
 
 
INDEX WORDS: Growth cone, Filopodia, Phosphatidylinositol-3-kinase, Nitric oxide, 
Filamentous actin, Akt, RhoA activated kinase, MEK, Helisoma trivolvis 
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Chapter 1 : General Introduction 
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Specific Aims of Dissertation 
Growth cones located at the tip of newly extended neurites are critical motile and sensory 
structures that are necessary for correct neuronal guidance during the development and 
regeneration of the nervous system. Filopodia, composed of bundles of F-actin, are the first sites 
of contact with guidance cues, and contact of a single filopodium is enough to reorient the 
growth cone toward or away from the contact point. The actin-based motility of growth cone 
filopodia is integral to correct guidance and subsequent connectivity. Therefore a better 
understanding of molecules and second messengers that regulate filopodial dynamics is crucial to 
prevent neuronal misguidance during the development or regeneration of the nervous system. 
The objective of this study is to determine the cellular mechanisms and second messengers 
involved in the regulation of growth cone dynamics. This dissertation employs Helisoma 
trivolvis as a model system to investigate: (i) the role of PI-3K and its downstream targets in 
regulating growth cone dynamics, and (ii) the effect of physiological concentrations of the 
gaseous messenger NO on growth cone morphology.  
 
Specific Aim 1 (Chapter 2): Does PI-3K and its downstream targets regulate filopodial 
dynamics? 
PI-3K has been demonstrated to regulate neurite outgrowth and to be expressed in growth cones 
(Rodgers and Theibert, 2002). These data suggest that PI-3K can regulate growth cone guidance, 
but does not provide information about the pathway through which PI-3K exerts its effect, or its 
role in the regulation of growth cone morphology. Therefore the present study tests the 
hypothesis that PI-3K affects filopodial dynamics and neurite outgrowth. Furthermore, this study 
hypothesizes that these effects are mediated through the lipid and protein kinase activities of PI-
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3K, and subsequently via Akt, Rho kinase (ROCK) and MEKK, ultimately affecting the 
dynamics of the actin cytoskeleton. 
 
Specific Aim 2 (Chapter 3): Determine whether NO release from a physiological source 
affects growth cone motility and examine the underlying signaling pathway. 
Global and local applications of NO via NO donors on Helisoma B5 neurons induce an increase 
in filopodial length, a decrease in filopodial number and an increase in [Ca2+]i (Van Wagenen 
and Rehder, 1999; Van Wagenen and Rehder, 2001; Welshhans and Rehder, 2005; Welshhans 
and Rehder, 2007). Local application of NO exerts its effect on growth cone morphology and 
calcium concentration via a signaling pathway involving sGC, cyclic guanosine monophosphate 
(cGMP), protein kinase G (PKG), and cyclic adenosine diphosphate ribose (cADPR) (Welshhans 
and Rehder, 2005; Welshhans and Rehder, 2007). These data suggest that NO can regulate 
growth cone dynamics during neuronal pathfinding. However the effect of NO release from a 
physiological source on growth cone morphology has never been investigated. The present study 
tests the hypothesis that NO which is spontaneously released from a single cell can affect growth 
cone dynamics of neighboring neurons in a paracrine fashion. Such a demonstration would 
provide evidence for NO acting as a paracrine messenger with the potential to affect the outcome 
of neuronal pathfinding.  
 
Overall, this dissertation investigates cellular mechanisms that control growth cone 
morphology during neuronal pathfinding. Identification of molecules and second messengers that 
affect growth cone dynamics has implications for clinical strategies to enhance correct 
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navigation and appropriate connectivity during development of the nervous system, and also 
during regeneration after injury.  
The complex wiring and rewiring of the nervous system during development and 
regeneration following injury require newly extended neurites to navigate long distances in order 
to reach their targets and form synapses. This neuronal pathfinding depends on a sensory and 
dynamic structure located at the tip of extending neurites, called the growth cone, on which 
spatially and temporally regulated extracellular cues bind to receptors and trigger intracellular 
signaling cascades that regulate cytoskeletal dynamics (Huber et al., 2003; Gallo and 
Letourneau, 2004). Many of these guidance cues and their receptors have now been identified; 
the guidance cues have been classified into two main categories by their action on growth cones, 
attractive or repulsive (Goodman, 1996; Tessier-Lavigne and Goodman, 1996; Huber et al., 
2003). In each category these cues can have an effect over a short distance (contact-dependent 
attraction or repulsion) or over a long distance (chemoattraction or chemorepulsion) (Goodman, 
1996; Tessier-Lavigne and Goodman, 1996; Huber et al., 2003). However, it has recently been 
shown that many individual cues can be both attractive and repulsive, depending (i) on the state 
of the growth cone, (ii) on the expression of specific receptors and (iii) cell type (Huber et al., 
2003; Nishiyama et al., 2003; Bartoe et al., 2006; McKenna et al., 2008). Although studies on 
extracellular cues and their effects on neuronal guidance have been well documented, less is 
known about the intracellular signaling mechanisms that regulate growth cone behavior. Thus, 
investigating signaling pathways and the integration of different signals in the growth cone will 
allow for a better understanding of mechanisms controlling neuronal pathfinding during 
development and regeneration of the nervous system. 
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Growth Cone Structure and Dynamics 
Growth cones, located at the tip of extending neurites, were observed in fixed chick embryonic 
tissues for the first time in the late 1800s by the Spanish neuroanotomist Ramon y Cajal. He 
described growth cones as “battering rams” finding their way through many obstacles to reach 
their targets, and already envisioned a guidance mechanism involving attractive gradients of 
diffusible cues released from their targets (Cajal, 1890). In 1910, growth cones were observed in 
embryonic neuronal tube explants by Ross Harrison (Harrison, 1910), and in vivo on growing 
nerve fibers in the transparent tail of a frog by Speidel in 1930 (Speidel, 1941). It has been 
shown that growth cones, isolated from their cell bodies in vivo, are still able to grow and 
navigate correctly to their final destinations (Bray et al., 1978; Harris et al., 1987), suggesting 
that growth cones themselves contain the machinery to sense and respond to guidance cues.  
The growth cone is composed of three regions: (i) the central domain, which contains 
microtubules and organelles, (ii) the lamellipodium, composed of a meshwork of filamentous 
actin (F-actin), and (iii) finger like extensions, called filopodia, made of bundles of F-actin 
(Smith, 1988; Huber et al., 2003) (Fig. 1.1). Guidance cues bind to receptors located on the 
membrane of filopodia, which continuously extend and retract to explore their environment. This 
area which is surveyed by the growth cone at any given point in time is called its ‘action radius’. 
Therefore, the ability of a growth cone to be dynamic is critical for correct pathfinding and 
application of drugs that interfere with filopodial dynamics result in pathfinding errors (Bentley 
and Toroian-Raymond, 1986; Chien et al., 1993). During the journey toward their targets, growth 
cone morphology and the speed of neurite advance changes at various points along their path 
(Tosney and Landmesser, 1985; Bovolenta and Mason, 1987). 
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Figure 1.1: Phase contrast image of a Helisoma trivolvis B5 growth cone. 
The growth cone contains 3 domains, the central domain (C), the lamellipodia (L), and filopodia 
(representative filopodia indicated by the arrows). 
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Growth cones fasciculating with pioneer axons have a simple bullet shape and grow 
faster, whereas growth cones reaching decision points become more complex, have more 
filopodia and lamellipodia and advance slower. Once growth cones reach their target region, 
their shape becomes thinner with many branches (Harris et al., 1987). As mentioned above, 
filopodia are the sensing devices of the growth cone and it has been shown that removal of 
filopodia will not prevent a growth cone from advancing but will affect correct navigation 
(Bentley and Toroian-Raymond, 1986; Chien et al., 1993). The importance of filopodia, and 
more specifically of single filopodia, in growth cone guidance has been demonstrated in vitro 
and in vivo. For example, contact of a single filopodium with a laminin-coated area in the culture 
dish or a guidepost cell results in the reorientation of the growth cone toward the contact point 
(O'Connor et al., 1990; Letourneau, 1996). In Helisoma neurons, stimuli known to induce an 
increase in the intracellular calcium concentration and/or changes in filopodial length, will cause 
the same effect on isolated filopodia, suggesting that filopodia can act as autonomous units 
(Davenport et al., 1993).  
What are the mechanisms controlling growth cone dynamics? Pharmacological studies 
identify F-actin as a key player in growth cone motility (Marsh and Letourneau, 1984; 
Letourneau et al., 1987) F-actin is polymerized in growth cones from G-actin monomers that are 
added at the plus end (barbed end) of F-actin at the leading edge of filopodia and lamellipodia. 
Actin filaments are very dynamic, involving actin polymerization at the plus end, retrograde flow 
toward the central domain (Zhou and Cohan, 2004), actin depolymerization at the minus end, 
and recycling of actin subunits for further actin polymerization (Lin et al., 1996; Mallavarapu 
and Mitchison, 1999; Jay, 2000; Suter and Forscher, 2000). Actin turnover has been shown to be 
critical for growth cone motility during pathfinding. Removal of filopodia on Ti1 pioneer growth 
 9
cones in the grasshopper limb in vivo by treatment with the actin depolymerizing agent, 
cytochalasin, induced misguidance (Bentley and Toroian-Raymond, 1986). Errors in pathfinding 
after treatment with cytochalasin were also observed in the Xenopus visual system, with retinal 
axons missing the tectum (Chien et al., 1993). These experiments, in addition to emphasizing a 
role of actin turnover in growth cone motility, suggest that filopodia are not necessary for neurite 
advance itself, but for correct pathfinding in response to guidance cues. The rate of filopodial 
elongation depends on both the rate of F-actin polymerization and retrograde flow (Mallavarapu 
and Mitchison, 1999). During pathfinding, growth cones will exhibit a variety of behaviors, such 
as collapse, and turning toward or away from gradients of guidance cues. These behaviors 
involve reorganization of the actin cytoskeleton in addition to regulation of actin turnover. 
Growth cones exposed to an attractive cue will have more and longer filopodia in the direction of 
the cue (Bentley and O'Connor, 1994; Zheng et al., 1996; Gallo et al., 1997), creating an 
asymmetrical cytoskeletal organization, which is critical for growth cone steering. Indeed, 
depolymerization of F-actin on one side of a growth cone with a local gradient of cytochalasin 
induces turning of the growth cone away from the gradient (Yuan et al., 2003).  
Microtubules have been recently suggested to be more than a secondary player in growth 
cone pathfinding (structural support for neurite advance), but instead to have a critical role in this 
process (Dent and Kalil, 2001; Gordon-Weeks, 2004; Kalil and Dent, 2005). In the axon, 
microtubules are organized in bundles and splay out once they enter the base of the growth cone, 
where a few invade the lamellipodium and some may even enter individual filopodia (Tsui et al., 
1984; Gordon-Weeks, 1991; Sabry et al., 1991; Zhou and Cohan, 2004). Microtubules, like F-
actin, are dynamic polymers, switching between phases of growth and shrinkage, with tubulin 
polymerization occurring at the plus end, which points toward the F-actin meshwork in the 
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peripheral domain (Heidemann et al., 1981; Kirschner and Mitchison, 1986; Baas et al., 1988). 
Pharmacological approaches have suggested a role for microtubule dynamics in growth cone 
steering. Pretreatment of Xenopus spinal neurons with taxol or nocodazole, drugs known to 
stabilize or destabilize microtubules, respectively, blocks the turning effect of glutamate and 
netrin-1. Local stabilization of microtubules on one side of Xenopus growth cones induces 
steering toward that side, whereas local destabilization induces turning away from the side 
exposed to nocodazole (Buck and Zheng, 2002). The similarity between the effects of blocking 
actin and microtubule dynamics, and the observation of interactions between these two polymers 
in the lamellipodium and individual filopodia suggest a possible interaction between 
microtubules and F-actin during growth cone steering by guidance cues.  
 
Guidance Cues and the Molecular Machinery of Growth Cones 
Rho GTPases and actin dynamics 
Studies on fibroblasts have identified small GTP-binding proteins of the Rho subfamily (Rho 
GTPases), such as Cdc42, Rac and Rho, as critical players in the formation of filopodia, 
lamellipodia, focal adhesions and stress fibers, respectively (Ridley and Hall, 1992; Ridley et al., 
1992; Nobes and Hall, 1995; Mueller, 1999). Injection of active Cdc42 into fibroblasts induced 
filopodial formation, whereas active Rac induced lamellipodial formation (Ridley et al., 1992; 
Kozma et al., 1995; Nobes and Hall, 1995). Development of stress fibers and focal adhesions 
were observed after injection of active Rho (Ridley and Hall, 1992; Nobes and Hall, 1995). 
Furthermore, in the nervous system, Rho GTPases are temporally expressed during axonal 
outgrowth in Drosophila, rats and chicken (Luo et al., 1994; Malosio et al., 1997; Threadgill et 
al., 1997). Additionally, RhoA effectors promote growth cone collapse and neurite retraction 
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(Wahl et al., 2000; Gallo and Letourneau, 2004). Rac-1 and Cdc42 have been found to regulate 
filopodial and lamellipodial dynamics in growth cones, and neurite guidance (Kuhn et al., 1998; 
Brown et al., 2000). During neuronal pathfinding, guidance cues bind and activate receptors on 
filopodia, which in turn regulate growth cone actin dynamics by activating Rho GTPases (Gallo 
and Letourneau, 1998; Dickson, 2001; Huber et al., 2003; Gallo and Letourneau, 2004). The 
activity state of Rho GTPases is determined by the binding of guanine nucleotides. Binding of 
GTP to Rho GTPases activates them, whereas GDP inactivates them. Two main classes of 
proteins control Rho GTPases activity, guanine nucleotide exchange factors (GEF) and GTPase 
activating factors (GAF). GEFs facilitate the exchange of GDP to GTP, which in turn activate 
Rho GTPases, whereas GAFs turn off their signaling by enhancing the endogenous GTPase 
activities of Rho GTPases (Hall, 1994; Dickson, 2001; Huber et al., 2003).  
Rho GTPases integrate signaling from many guidance cues, leading to specific growth 
cone behaviors such as turning, branching, and collapse by controlling actin polymerization, 
branching, actin depolymerization and retrograde flow. Recent studies have unraveled the 
mechanisms by which Rho GTPases regulate actin dynamics. Cdc42 and Rac induce actin 
nucleation and branching by activating the Arp2/3 complex through the effectors neuronal 
Wiskott-Aldrich Syndrome protein (N-WASP) and SCAR/WAVE, respectively (Machesky et 
al., 1999; Rohatgi et al., 1999). Actin polymerization is controlled by (i) the protein profilin, 
which binds to G-actin monomers, facilitating their addition at the plus end of F-actin and (ii) its 
effectors, proteins from the VASP/Ena family, which in addition to activating profilin also 
associate with the plus end of F-actin and prevent the binding of capping proteins (Suetsugu et 
al., 1998; Bear et al., 2002). Actin depolymerization at the minus end involves the F-actin 
severing protein, cofilin. The activity of cofilin is regulated by phosphorylation and 
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dephosphorylation, with inactivation induced by phosphorylation through LIM kinase (LIMK) 
(Arber et al., 1998; Yang et al., 1998), and activation caused by dephosphorylation via the 
phosphatase Slingshot (Niwa et al., 2002). LIMK is activated by p21-activated kinase (PAK), the 
effector of Cdc42 and Rac, and by ROCK, the effector of RhoA (Arber et al., 1998; Yang et al., 
1998). Rho GTPases control F-actin retrograde flow by regulating non-muscle myosin via 
phosphorylation by ROCK or myosin light chain kinase (MLCK), the latter being inactivated by 
PAK, the effector of Rac and Cdc42 (Amano et al., 1996; Sanders et al., 1999). To summarize, 
during neuronal pathfinding, guidance cues can regulate growth cone behavior through 
RhoGTPase signaling, which mediates the activation of actin binding proteins (ABPs).  
 
Guidance cues and RhoGTPases 
During development of the nervous system, guidance cues guide extending neurites by 
regulating growth cone actin dynamics. However, it remains to be deteremined which 
RhoGTPases mediate the effect of particular guidance cues. In this section I will briefly 
introduce only the guidance cues known to mediate their effect via RhoGTPase signaling.  
The diffusible factor netrin has been shown to act bifunctionally in vertebrates, being 
attractive for spinal cord commissural axons to the floor plate and repulsive for trochlear motor 
axons (Kennedy et al., 1994; Colamarino and Tessier-Lavigne, 1995). Furthermore, netrin 
receptors have been identified: attractive receptors are UNC-40, DCC and Frazzled in C.elegans, 
vertebrate and Drosophila respectively (Chan et al., 1996; Keino-Masu et al., 1996; Kolodziej et 
al., 1996), whereas UNC-5 and UNC 40 have been shown to mediate repulsion in C. elegans 
(Amano et al., 1996; Chan et al., 1996; Ackerman et al., 1997; Leonardo et al., 1997; Mueller, 
1999). In vertebrates, netrin-1-DCC signaling involves the RhoGTPases, Rac and Cdc42. 
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Coexpression of DCC, and dominant negative forms of Rac and Cdc42 in HEK 293T cells or 
neuroblastoma cells blocks the effect of netrin-1 on filopodial number and cell morphology 
(Shekarabi and Kennedy, 2002). Furthermore, Rac1 and Cdc42 activities have been shown to be 
necessary for DCC-induced neurite outgrowth in N1E-115 neuroblastoma cells (Li et al., 2002). 
Netrin-1 affects growth cone dynamics via cyclic nucleotides, and the intrinsic level of cyclic 
nucleotides modulates the effect of netrin-1. For example, experiments using growth cone 
turning assays indicated that high levels of cyclic adenosine monophosphate (cAMP) mediated 
netrin-1 induced attraction, whereas low levels of cAMP mediated netrin-1 induced repulsion of 
embryonic Xenopus spinal neurons (Ming et al., 1997; Song et al., 1997).  
Semaphorins, which can be both diffusible and membrane bound, can also act as either 
attractive or repulsive guidance cues (Messersmith et al., 1995; Shepherd et al., 1997; Varela-
Echavarria et al., 1997). In vitro studies on chick dorsal root ganglion neurons suggest a role for 
Rac1 in mediating collapsin1- or semaphorin3A-induced growth cone collapse (Jin and 
Strittmatter, 1997). Activation of RhoA seems to be critical for semaphorin4-induced growth 
cone collapse (Huber et al., 2003). Similar to netrin, semaphorin signaling involves cyclic 
nucleotides. Indeed, cyclic guanosine monophosphate (cGMP) modulates the effect of 
semaphorin3 on growth cone motility, because  growth cone repulsion can be converted to 
attraction by increasing the intracellular level of cGMP (Song and Poo, 1999). 
Another type of repulsive cue, ephrins, which bind to their tyrosine kinase receptors 
Ephs, play a role in the formation of topographic maps (Cheng et al., 1995; Drescher et al., 
1997), patterning of forebrain and hindbrain (Xu et al., 1995; Xu et al., 1996), and the formation 
of certain commissures (Orioli et al., 1996; Park et al., 1997). EphA receptors interact with 
glycosylphosphatidylinositol (GPI) anchored ephrin A ligands, whereas EphB receptors bind to 
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ephrin B transmembrane ligands (Frisen and Barbacid, 1997). A particularity of these ligands is 
that their signaling is bidirectional, meaning that binding of ligands to receptors triggers 
signaling in the cell expressing the receptor (forward signaling), as well as in the ligand-
expressing cell (backward signaling) (Kullander and Klein, 2002). Ephrin signaling involves 
RhoGTPase activation; for example, ephrin-A5 has been shown to induce growth cone collapse 
of retinal ganglion cells though activation of RhoA and its effector ROCK (Wahl et al., 2000). 
Furthermore, retinal axon retraction in response to ephrin-A2 involves RhoA and Rac1 signaling 
(Gallo et al., 2002; Jurney et al., 2002).  
Neurotrophins, such as nerve growth factor (NGF), brain derived neurotrophic factor 
(BDNF), and neurotrophin 3 and 4 (NT-3 and NT-4) have been well documented to play a role in 
neuronal growth and survival during the development of the nervous system in vivo (Huang and 
Reichardt, 2001); however, recent studies in vitro suggest that they also have the ability to act as 
potent guidance cues. For example, NGF induces attractive turning of chick dorsal root and 
retinal axons (Gundersen and Barrett, 1979; Gallo et al., 1997). In addition, these four 
neurotrophins have been shown to induce growth cone turning of Xenopus spinal neurons in vitro 
(Song et al., 1997; Ming et al., 1999). Neurotrophins bind with high affinity to tropomyosin 
related kinase (Trk) receptors, which are tyrosine kinase receptors. NGF binds to TrkA, BDNF to 
TrkB and NT-3 to TrkC. Stimulation of TrkA by NGF induces the activation of Cdc42 and Rac, 
as well as the inactivation of RhoA (Sebok et al., 1999; Yamaguchi et al., 2001; Nusser et al., 
2002). Inhibition of the RhoA effector, ROCK, blocks NGF induced growth cone steering 
(Loudon et al., 2006). These results strongly suggest a role for RhoGTPases in NGF-mediated 
regulation of neurite outgrowth. Neurotrophins also bind with low affinity to another type of 
receptor, the p75 receptor. P75 has been suggested to bind RhoA directly and to inactivate it 
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upon binding of neurotrophins (Yamashita et al., 1999). Indeed, BDNF induces filopodial 
elongation on chick retinal growth cones by inactivating RhoA through p75 stimulation (Gehler 
et al., 2004). As observed with netrin-1 and semaphorin, the attractive effect of BDNF and NGF 
can be converted to repulsion by decreasing the cAMP level (Song et al., 1997). 
As mentioned earlier, neurites can be guided by short range guidance cues through 
contact with cues in the extracellular matrix (ECM), or cell adhesion molecules (CAM) 
expressed on both pathfinding neurons and neighboring cells (Tessier-Lavigne and Goodman, 
1996). Cell adhesion receptors include immunoglobulin (Ig) family members such as NCAM, as 
well as cadherins and integrins. Binding of these receptors to ligands in the ECM or to CAM on 
neighboring cells triggers signaling pathways that affect neurite outgrowth. Mitogen activated 
protein kinase (MAPK) pathways have been well documented to mediate cell adhesion receptor 
signaling (Tessier-Lavigne and Goodman, 1996; Huber et al., 2003). In addition to MAPK 
pathways, integrins and cadherins can also activate RhoGTPase signaling (Clark et al., 1998; 
Kaibuchi et al., 1999; Ren et al., 1999). 
 
Role of the Second Messenger Calcium in Axonal Guidance 
Importance of calcium in growth cone motility and steering 
Calcium (Ca2+) is an important second messenger that relays guidance cues to regulate growth 
cone motility and steering (Song and Poo, 1999; Gomez and Spitzer, 2000; Henley and Poo, 
2004). The intracellular calcium concentration ([Ca2+]i) in the growth cone is regulated by 
several mechanisms, such as influx through plasma membrane Ca2+ channels, release from 
internal stores (mitochondria and endoplasmic reticulum) through inositol-3 phosphate (IP3) and 
ryanodine sensitive channels, and extrusion through plasma membrane adenosine triphosphate 
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dependent pumps and sodium-calcium exchangers (Lipscombe et al., 1988; Clapham, 1995; 
Henley and Poo, 2004; Wen and Zheng, 2006). Calcium has been shown to play a role in neurite 
outgrowth, but early studies from different research groups were not consistent and sometimes 
even conflicting. Some groups demonstrated that Ca2+ facilitated neurite outgrowth (Nishi and 
Berg, 1981; Suarez-Isla et al., 1984) while others suggested that Ca2+ prevented it (Bixby and 
Spitzer, 1984; Mattson and Kater, 1987; Silver et al., 1989). An explanation for this range of 
responses was provided by the hypothesis of a “Ca2+ set point” (Kater and Mills, 1991) stating 
that within an optimal range of [Ca2+]i neurites grow at their maximal speed, but that changes of 
[Ca2+]i below or above the optimal range will slow down or stop growth cone motility. In 
addition to regulating neurite outgrowth, [Ca2+]i plays a critical role in growth cone steering. 
Application of an electric field affects the speed of neurite advance of Xenopus spinal neurons 
and mouse dorsal root ganglion neurons and induces growth cone steering toward the cathode 
(Hinkle et al., 1981; Patel and Poo, 1982; Fields et al., 1990). Interestingly, the effect of electric 
fields on growth cone motility is mediated by a local increase in [Ca2+]i (Bedlack et al., 1992; 
Davenport and Kater, 1992).  
Guidance cue-induced growth cone steering, such as seen with netrin-1, NGF, BDNF and 
myelin associated glycoprotein (MAG), also requires Ca2+ signaling (Song et al., 1997; Hong et 
al., 2000; Henley et al., 2004). For example, a gradient of netrin-1 has been shown to induce 
growth cone attraction by increasing [Ca2+]i via calcium influx through voltage dependent Ca2+ 
channels (Hong et al., 2000; Niwa et al., 2002; Nishiyama et al., 2003). Furthermore, recent 
studies have demonstrated a role of transient receptor potential (TRP) channels in netrin-1, 
BDNF and MAG induced growth cone steering (Li et al., 2005; Shim et al., 2005; Wang and 
Poo, 2005). Growth cone steering requires an asymmetric increase of [Ca2+]i in the growth cone. 
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For example, local increases of [Ca2+]i in Xenopus and dorsal root ganglion growth cones by 
using a gradient of ryanodine or Ca2+ ionophore respectively, is sufficient to induce growth cone 
steering (Gundersen and Barrett, 1980; Hong et al., 2000). These results are further supported by 
experiments using focal photolysis of caged Ca2+ to induce growth cone turning (Zheng, 2000). 
Surprisingly a local increase in [Ca2+]i in growth cones induces both attraction and repulsion, 
depending on the amplitude of the increase. Focal photolysis of caged Ca2+ in the presence of 
extracellular Ca2+ induces attraction of growth cones, whereas when the resting level of [Ca2+]i is 
decreased in the absence of extracellular Ca2+, the same focal release induces repulsion (Zheng, 
2000). Gradients of netrin-1 and MAG induce growth cone attraction and repulsion, respectively, 
by increasing [Ca2+]i on the side of the gradient. Netrin-1 causes a higher increase in [Ca2+]i than 
MAG, mediated by both Ca2+ influx through plasma membrane Ca2+ channels and Ca2+-induced 
Ca2+ release from internal stores, whereas MAG acts through Ca2+ release from internal stores 
only (Hong et al., 2000; Nishiyama et al., 2003; Henley et al., 2004). To summarize, a global 
increase in [Ca2+]i affects neurite outgrowth, whereas a local increase mediates growth cone 
steering.  
It is also important to note that transient increases in [Ca2+]i localized to filopodia have 
been observed during neurite outgrowth in vitro, with the local increase in [Ca2+]i propagating to 
the central domain, and leading to a global increase in [Ca2+]i (Gomez et al., 2001). Experiments 
in our laboratory have investigated the effect of spatio-temporal increases in [Ca2+]i on filopodial 
dynamics of Helisoma B5 neurons. Global and regional uncaging of Ca2+ in the growth cone 
induced a global increase in filopodial length, whereas local release within an individual 
filopodium induced elongation that was restricted to the stimulated filopodium (Cheng et al., 
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2002). These results suggest a critical role for spatio-temporal Ca2+ signaling in neuronal 
pathfinding. 
 
Calcium signaling 
The effect of calcium signaling on neurite outgrowth and growth cone steering is mediated by 
changes in cytoskeleton dynamics. A well documented effector of Ca2+ is the Ca2+ binding 
protein, calmodulin (CaM). CaM is highly expressed in filopodia and the central domain of 
growth cones, and is sensitive to [Ca2+]i just above basal calcium levels (Zucker, 1999). 
Inhibition of CaM induces mistakes in pathfinding in vivo (VanBerkum and Goodman, 1995), 
and prevents laminin-induced growth cone attraction in vitro (Kuhn et al., 1998). Calcium-
calmodulin activates calcium/calmodulin-dependent kinases (CaMK) and the phosphatase 
calcineurin (Henley and Poo, 2004). Uncaged Ca2+-induced filopodial elongation in Helisoma 
B5 neurons is mediated by activation of CaM and calcineurin (Cheng et al., 2002). Furthermore, 
recent studies in Xenopus and other organisms have shown that overexpression of active CaMKII 
facilitates neurite outgrowth, whereas inhibition prevents it (Goshima et al., 1993; Kuhn et al., 
1998; Zou and Cline, 1999). Calcineurin also prevents neurite outgrowth in Xenopus spinal 
neurons and promotes it in chick dorsal root ganglion neurons (Chang et al., 1995; Lautermilch 
and Spitzer, 2000). Another protein mediating Ca2+ signaling is protein kinase C, which is 
activated by calcium and phosphorylates a number of proteins, including GAP-43 (Liu and 
Storm, 1990). Phosphorylation of GAP-43 by PKC results in the dissociation of GAP-43 from 
CaM, allowing free CaM to be activated by Ca2+ (Liu and Storm, 1990). It is important to note 
that phosphorylated GAP-43 stabilizes F-actin, whereas dephosphorylation by calcineurin 
destabilizes it (He et al., 1997). Furthermore, PKC has been shown to mediate growth cone 
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turning in Xenopus spinal neurons and growth cone dynamics in Helisoma B5 neurons (Cheng et 
al., 2000; Xiang et al., 2002). Another downstream protein of Ca2+ signaling is myosin II, which 
is activated by phosphorylation via Ca2+/CaM dependent myosin light chain kinase and/or by 
ROCK (Amano et al., 1996; Dent and Gertler, 2003), and inactivated by RhoGTPases, Cdc42 
and Rac (Sanders et al., 1999). To summarize, calcium is a critical second messenger regulating 
growth cone dynamics during neuronal pathfinding.  
 
Phosphatidylinositol-3-Kinase (PI-3K) 
PI-3K signaling 
PI-3K has been implicated in a variety of cellular activities, including cell survival, mitogenesis, 
and differentiation (Krasilnikov, 2000; Rodgers and Theibert, 2002). There are three classes of 
PI-3K: Class I contains a p110 catalytic subunit and a regulatory adapter subunit, and 
preferentially phosphorylates phosphatidylinositol 4,5 biphosphate [PtdIns(4,5)P2] to 
PtdIns(3,4,5)P3 (Vanhaesebroeck and Waterfield, 1999; Cantrell, 2001). Class II phosphorylates 
PtdIns and PtdIns(4)P to PtdIns(3)P and PtdIns(3,4)P2 respectively, whereas class III 
phosphorylates only PtdIns to PtdIns(3)P (Vanhaesebroeck and Waterfield, 1999; Cantrell, 
2001). Class I PI-3K can be activated by receptor- and non-receptor tyrosine kinases, as well as 
by G-protein coupled receptors (Stephens et al., 1994; Stoyanov et al., 1995; Lopez-Ilasaca et al., 
1997; Duronio et al., 1998; Vanhaesebroeck and Waterfield, 1999; Cantrell, 2001). PI-3K, in 
turn, has two modes of action. First of all, it functions as a lipid kinase by phosphorylating the 
3’-OH position on the inositol ring of several phosphoinositides, thereby producing inositol lipid 
products, which are important mediators of intracellular signaling (Duronio et al., 1998; 
Vanhaesebroeck and Waterfield, 1999; Cantrell, 2001). This signaling pathway leads to the 
 20
stimulation of guanine nucleotide exchange factors for Rho-GTPases, as well as to the activation 
of the PH-domain containing kinase, PDK-1, which in turn activates Akt (Alessi et al., 1997; 
Downward, 1998; Meier and Hemmings, 1999; Vanhaesebroeck and Alessi, 2000). Secondly, 
PI-3K functions as a protein kinase resulting in the activation of the Ras/Raf/Erk and Cdc42/Rac 
pathways (Bondeva et al., 1998; Vanhaesebroeck and Waterfield, 1999; Krasilnikov, 2000). Both 
the lipid and the protein kinase activities of PI-3K regulate downstream targets known to affect 
actin cytoskeletal organization (Rodgers and Theibert, 2002), suggesting a potential role of PI-
3K in growth cone dynamics.  
 
Role of PI-3K in the nervous system 
Developing and adult rat brains express PI-3K (Ito et al., 1995; Bartlett et al., 1999; Rodgers and 
Theibert, 2002) and upregulation of PI-3K has been observed after axonal crush and ischemia 
(Ito et al., 1996; Kitagawa et al., 1999). An increase in PI-3K activity and protein level occurs in 
amyotrophic lateral sclerosis (Wagey et al., 1998), whereas a decrease in PI-3K activity is 
observed in Alzheimer’s disease (Zubenko et al., 1999). The function of PI-3K in neuronal 
survival is well established (Yao and Cooper, 1995; Rodgers and Theibert, 2002). In addition to 
its involvement in mediating cell survival, PI-3K has been reported to stimulate neurite 
outgrowth in PC12 cells (Kita et al., 1998), to mediate ephrin A5 and slit-2 induced growth cone 
collapse in chick retinal ganglion cells (Wong et al., 2004), and to be required for the NCAM-
mediated neurite outgrowth of primary neurons (Ditlevsen et al., 2003). In addition, PI-3K has 
been shown to play a role in lamellipodial formation of PC12 cells (Posern et al., 2000) and in 
the regulation of neuronal polarity (Shi et al., 2003; Menager et al., 2004). These effects are 
likely mediated by changes at the level of the neuronal cytoskeleton. The mechanism by which 
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PI-3K affects neurite outgrowth is presently unclear, but prominent targets downstream of PI-3K 
include Akt (Protein kinase B), regulators of Rho-GTPase family members, and the 
RAS/RAF/ERK pathway (Corvera and Czech, 1998; Duronio et al., 1998; Vanhaesebroeck and 
Waterfield, 1999; Bishop and Hall, 2000; Krasilnikov, 2000; Cantrell, 2001). Studies have 
shown that expression of a dominant inhibitory form of Akt increases NGF-induced neurite 
outgrowth in PC12 cells (Bang et al., 2001; Piiper et al., 2002). Yet, pharmacological inhibition 
of PI-3K reduces neurite outgrowth in mouse DRG and hippocampal neurons (Wu et al., 1998; 
Edstrom and Ekstrom, 2003), as well as in PC12 cells (Jackson et al., 1996). Furthermore, PI-3K 
activation by NGF has been shown to increase axon outgrowth in DRG neurons by inactivation 
of GSK-3ß and subsequent involvement of the microtubule plus end binding protein APC (Zhou 
et al., 2004), although NGF stimulation has also been reported to signal via the MAPK pathway 
(Goold and Gordon-Weeks, 2005). To summarize PI-3K may regulate neurite outgrowth via Akt 
and MAPK pathway. 
 
Role of the Gaseous Second Messenger Nitric Oxide (NO) in the Nervous System 
NO signaling 
NO is a gas produced by the enzyme nitric oxide synthase (NOS), which is known to have 3 
isoforms: neuronal (nNOS), inducible (iNOS) and endothelial (eNOS) (Garthwaite, 1991). 
Activation of cells containing iNOS, such as macrophages, microglia and astrocytes, during 
disease and injury leads to the production of NO (Hall, 1994; Cassina et al., 2002). Like other 
free radicals, NO in high concentrations can be toxic due its formation of reactive nitrogen 
species (RNS) such as peroxynitrite (ONOO-), via the reaction of nitric oxide and superoxide 
(Lewen et al., 2000). A main target of NO is the enzyme soluble guanylyl cyclase (sGC), which 
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once activated by the binding of NO to its heme moiety (Dierks and Burstyn, 1996), forms 
cGMP. cGMP can increase [Ca2+]i by activating PKG, which in turn can activate ryanodine-
sensitive calcium stores located in the endoplasmic reticulum (Willmott et al., 1996; Looms et 
al., 2001; Vicente et al., 2005). cGMP can also increase [Ca2+]i by activating cyclic nucleotide-
gated ion (CNG) channels located in the plasma membrane. This is achieved by cGMP elevating 
the concentration of cAMP through inhibition of phosphodiesterase III (PDEIII) (Houslay and 
Milligan, 1997; Tsukada et al., 2002; Jensen et al., 2004). Recent studies have reported a role for 
Ca2+/Calmodulin in the formation of NO through activation of some NOS isoforms (Bredt and 
Snyder, 1990; Cho et al., 1992; Li and Poulos, 2005). Other mechanisms of NO action are 
exerted via nitrosylation of cysteine residues in proteins to produce S-Nitrosothiols (Arnold et 
al., 1977; Stamler et al., 1992; Jaffrey et al., 2001; Ahern et al., 2002), and nitration of tyrosine 
residues (Ischiropoulos, 1998). In addition to its effect on protein regulation, NO can also act on 
DNA (Wink et al., 1991). 
 
NO and the nervous system 
In the central nervous system (CNS), NO has been described as a neuromodulator involved in 
long-term potentiation during learning and memory (O'Dell et al., 1994; Brenman and Bredt, 
1996; Son et al., 1996). Recent studies report that presynaptic plasticity induced during activity-
dependent synaptogenesis is regulated by NO (Nikonenko et al., 2003; Zhang et al., 2005). NO 
has also been suggested to play an important role in the formation of retinal projections during 
neuronal development in vivo (Williams et al., 1994; Cramer et al., 1996; Gibbs and Truman, 
1998; Cramer and Sur, 1999; Ernst et al., 1999; Wildemann and Bicker, 1999; Wu et al., 2000). 
For example, inhibition of nNOS by pharmacological blockers was shown to prevent the 
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elimination of transient ipsilateral retinotectal projections in the chick visual system, and to 
affect retinogeniculate projection patterns in ferret (Wu et al., 1994; Cramer and Sur, 1999).  
Moreover, NO has been reported to be involved in neuronal differentiation and neurite 
outgrowth. Neuronal differentiation of NGF-induced PC12 cells is dependent on NO (Peunova 
and Enikolopov, 1995; Nakaya et al., 2000). However, the role of NO on neurite outgrowth is 
controversial. Some groups have reported that NO induces growth cone collapse and neurite 
retraction (Hess et al., 1993; Ernst et al., 1999; Gallo et al., 2002), and others have reported that 
NO facilitates neurite outgrowth (Hindley et al., 1997; Poluha et al., 1997; Rialas et al., 2000). 
During the development of the grasshopper embryo, NO, potentially released from epithelial 
cells facing the basal lamina of the developing antenna, has been shown to regulate axonal 
pathfinding of antennal pioneer neurons (Seidel and Bicker, 2000; Bicker, 2007). We have 
shown previously that NO donors applied to identified Helisoma B5 neurons grown in vitro 
results in an increase in filopodial length and a concomitant decrease in neurite outgrowth (Van 
Wagenen and Rehder, 1999; Trimm and Rehder, 2004; Welshhans and Rehder, 2005), 
suggesting that some of the developmental effects of NO described in the literature might result 
from NO acting on neuronal growth cones. A recent study, in which NO donors were applied 
focally to B5 growth cones, indeed confirmed that NO regulates filopodial motility locally at the 
growth cone and that the NO signaling pathway included soluble guanylyl cyclase (sGC), protein 
kinase G (PKG), cyclic adenosine diphosphate ribose (cADPR) and intracellular calcium release 
from ryanodine sensitive stores (Welshhans and Rehder, 2005; Welshhans and Rehder, 2007). In 
addition, a follow up study demonstrated that NO release from a single cell has a physiological 
effect on growth cone dynamics of neighboring neurons in vitro (Tornieri and Rehder, 2007).  
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NO has also been suggested to have pathological effects in neurodegenerative diseases 
and in CNS injury (Ruan et al., 1995; Beckman et al., 2001; Tabner et al., 2002). Recents studies 
have highlighted a controversy in the role of NO in neuronal regeneration. Upregulation of NOS 
expression has been associated with the degeneration of spinal motoneurons (Wu and Scott, 
1993; Wu et al., 1994; Wu, 1996) and with the death of Purkinje neurons (Chen and Aston-
Jones, 1994) following injury. However, upregulation of NOS expression has also been 
correlated with axonal regeneration after injury of cranial motoneurons (Yu, 1994). A 
regenerative delay due to a decelerated Wallerian degeneration has been reported in NOS 
knockout mice (Keilhoff et al., 2002). Recently, NO has also been demonstrated to promote 
axonal regeneration following injury in locust embryos (Stern and Bicker, 2008). Furthermore, 
iNOS and nNOS have been reported to have a neuroprotective role in the olfactory 
neuroepithelium (Min et al., 2003), and peroxynitrite has been suggested to be involved in 
cellular survival at low concentrations (Bolanos et al., 2004). The difference in cell types and 
species used in the studies mentioned above may explain this discrepancy on the role of NO 
following CNS injury.  
 
Helisoma trivolvis as a Model System to Study Neuronal Pathfinding during Development 
and Regeneration Following Injury 
Transplantation of embryonic neuronal tissues (Low et al., 1982), solid grafts (Lindvall et al., 
1990), and neuronally derived cells (Baron-Van Evercooren, 1994) has been used with limited 
success in mammalian models to enhance neuronal regeneration beyond the glial scar. Because 
regeneration occurs in the CNS of Helisoma trivolvis, it is a well-established model system to 
study neuronal regeneration following injury in vivo (Murphy and Kater, 1980; Berdan et al., 
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1990; Murrain et al., 1990; Berdan and Easaw, 1992) and in vitro (Rehder et al., 1992; Geddis 
and Rehder, 2003; Geddis and Rehder, 2003). Helisoma has a simple, well characterized nervous 
system, and the large size (up to 100 µm) and consistent position of the neuronal cell bodies in 
its ganglia permits (i) the injection of tracer dyes into identified neurons to assess changes in 
morphology during regeneration (Murphy and Kater, 1980; Berdan et al., 1990; Berdan and 
Easaw, 1992), and (ii) isolation of identified neurons into primary culture. Identification of 
individual neurons in different animals by their morphology, color, location and size allows for 
elimination of variability due to a heterogeneous population of neurons. In addition, the ability to 
maintain organ and cell culture allows for complete control over the environment during the 
experiment. To address the specific aims of my dissertation, I performed experiments using 
primary cell culture of two identified neurons (neurons B5 and B19) located in the buccal 
ganglion, which controls the feeding behavior of the snail.  
 
Morphology and characteristic of B5 and B19 buccal neurons 
In vivo one single axon of the B5 neuron exits the buccal ganglion through the esophageal nerve 
trunk and branches near the salivary gland (i) to innervate the esophagus via the gastric nerve 
and (ii) to innervate the buccal mass via the dorsobuccal nerve trunk (Berdan RC, 1989; Berdan 
et al., 1990). B5 neurons are cholinergic and nitergic neurons, in which electrical activity is 
modulated by glutamate (Haydon et al., 1990; Zoran et al., 1990; Van Wagenen and Rehder, 
2001; Scannell et al., 2008). The B19 neuron innervates the supralateral radular tensor muscle of 
the buccal mass (Berdan RC, 1989; Zoran et al., 1990). B19 neurons are cholinergic neurons, in 
which glutamate affects electrical activity, and serotonin and dopamine decrease neurite 
outgrowth (Haydon et al., 1984; Cohan et al., 1987; McCobb et al., 1988; Haydon et al., 1990; 
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Murrain et al., 1990; Zoran et al., 1990; Davenport et al., 1993; Scannell et al., 2008). The fact 
that B19 neurons do not express nNOS and sGC, as opposed to B5 neurons, makes them a good 
control in experiments investigating the role of NO (Van Wagenen and Rehder, 2001; Tornieri 
and Rehder, 2007). 
 
Helisoma growth cones 
The large size of growth cones from neurons grown in culture (up to 50 µM) makes Helisoma 
trivolvis a great system to study growth cone dynamics. Neurons cultured in defined medium 
(without growth factors) form short neurites with large non-motile growth cones (Williams and 
Cohan, 1994), suggesting that growth cone formation is an intrinsic property, whereas neurite 
advance requires growth factors. These large growth cones permit the investigation of 
cytoskeletal changes during growth cone dynamics (Cohan et al., 2001; Zhou and Cohan, 2001). 
On the other hand, culturing neurons in conditioned medium (containing growth factors) induces 
the formation of extended neurites tipped with motile growth cones (Williams and Cohan, 1994), 
suggesting that neurite extension requires growth factors. The morphology and motility of B5 
and B19 growth cones differ, with B5 growth cones having shorter and more filopodia than B19 
growth cones (Haydon et al., 1985). In terms of outgrowth, B5 growth cones advance faster than 
B19 ones (Haydon et al., 1985). To summarize, the simplicity of its nervous system, the large 
size and accessibility of its neurons, and the fact that its CNS can regenerate leads to the use of 
H. trivolvis as a favorable system to investigate neuronal pathfinding. 
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Chapter 2 : Control of Neurite Outgrowth and Growth Cone Motility by 
Phosphatidylinositol-3-Kinase 
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Abstract 
Phosphatidylinositol-3-kinase (PI-3K) has been reported to affect neurite outgrowth both 
in vivo and in vitro. Here we investigated the signaling pathways by which PI-3K affects neurite 
outgrowth and growth cone motility in identified snail neurons in vitro. Inhibition of PI-3K with 
wortmannin (2 µM) or LY 294002 (25 µM) resulted in a significant elongation of filopodia and 
in a slow-down of neurite outgrowth. Experiments using cytochalasin and blebbistatin, drugs that 
interfere with actin polymerization and myosin II activity, respectively, demonstrated that 
filopodial elongation resulting from PI-3K inhibition was dependent on actin polymerization. 
Inhibition of strategic kinases located downstream of PI-3K, such as Akt, ROCK and MEK, also 
caused significant filopodial elongation and a slow-down in neurite outgrowth. Another growth 
cone parameter, filopodial number, was not affected by inhibition of PI-3K, Akt, ROCK, or 
MEK. A detailed study of growth cone behavior showed that the filopodial elongation induced 
by inhibiting PI-3K, Akt, ROCK and MEK was achieved by increasing two motility parameters: 
the rate with which filopodia extend (extension rate) and the time that filopodia spend 
elongating. Whereas the inhibition of ROCK or Akt (both activated by the lipid kinase activity of 
PI-3K) and MEK (activated by the protein kinase activity of PI-3K) had additive effects, 
simultaneous inhibition of Akt and ROCK showed no additive effect. We further demonstrate 
that the effects on filopodial dynamics investigated were calcium-independent. Taken together, 
our results suggest that inhibition of PI-3K signaling results in filopodial elongation and a slow-
down of neurite advance, reminiscent of growth cone searching behavior. 
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Introduction 
During development growth cones play an important role in guiding neuronal processes 
to their targets. Growth cones function by integrating intracellular signals that are elicited by the 
binding of extracellular cues to membrane-bound or intracellularly located receptors, and by 
translating these signals into a coordinated motor output that results in directed neurite advance. 
The filopodia on growth cones undergo continuous cycles of extension and retraction, thereby 
placing their receptors at varying distances from the growth cone proper and resulting in changes 
in the ‘sensory radius’ of the growth cone. Filopodial length and neurite outgrowth are under the 
control of extracellular cues, and several treatments, mainly acting through an increase in the 
intracellular calcium concentration have been demonstrated to cause a transient increase in 
filopodial length (Davenport and Kater, 1992; Rehder and Kater, 1992; Cheng et al., 2002) and a 
decrease in neurite extension (Cohan et al., 1987; Mattson and Kater, 1987; Lankford and 
Letourneau, 1989; Kater and Mills, 1991; Neely, 1993). 
Phosphatidylinositol-3-kinase (PI-3K) has been implicated in a variety of cellular 
activities, including cell survival, mitogenesis, and differentiation (Krasilnikov, 2000; Rodgers 
and Theibert, 2002). PI-3K is activated by binding to receptor- and non-receptor tyrosine 
kinases, as well as by G-protein coupled receptors, and its activation is known to affect multiple 
targets (Raffioni and Bradshaw, 1992; Soltoff et al., 1992; Soltoff et al., 1992; Duronio et al., 
1998; Wymann and Pirola, 1998; Virdee et al., 1999; Krasilnikov, 2000; Cantrell, 2001). In 
addition to its involvement in mediating cell survival, PI-3K has been reported to stimulate 
neurite outgrowth in PC12 cells (Kita et al., 1998), to mediate ephrin A5 and slit-2 induced 
growth cone collapse in chick retinal ganglion cells (Wong et al., 2004), and to be required for 
the NCAM-mediated neurite outgrowth of primary neurons (Ditlevsen et al., 2003). In addition, 
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PI-3K has been shown to play a role in lamellipodial formation of PC12 cells (Posern et al., 
2000) and in the regulation of neuronal polarity (Shi et al., 2003; Menager et al., 2004). These 
effects are likely mediated by changes at the level of the neuronal cytoskeleton. The mechanism 
by which PI-3K affects neurite outgrowth is presently unclear, but prominent targets downstream 
of PI-3K include Akt (PKB), regulators of Rho-GTPase family members, and the 
RAS/RAF/ERK pathway (Corvera and Czech, 1998; Duronio et al., 1998; Vanhaesebroeck and 
Waterfield, 1999; Bishop and Hall, 2000; Krasilnikov, 2000; Cantrell, 2001). To determine 
whether the effect of PI-3K activity on neurite outgrowth might be explained by PI-3K affecting 
growth cone motility through its effects on the neuronal cytoskeleton, we here studied several 
key targets within the larger PI-3K signaling cascade to investigate the signaling pathway by 
which PI-3K affects the actin cytoskeleton of neuronal growth cones.   
PI-3K has a double-enzymatic activity, that of a lipid kinase and a protein kinase (Dhand 
et al., 1994; Krasilnikov, 2000). The protein kinase activity regulates the PKC, Ras/ERK, and 
Rac/JNKK/JNK signaling pathways, whereas the lipid kinase activity controls the Akt anti-
apoptotic signaling pathway and the activity of Rho kinase (ROCK) (Krasilnikov, 2000; Cantley, 
2002). By using two inhibitors of PI-3K, wortmannin and LY 294002, we show that PI-3K 
activity is involved in regulating both neurite outgrowth and filopodial dynamics. We further 
show that this regulation involved members of the lipid kinase (ROCK or Akt) and the protein 
kinase (MEK) pathways of PI-3K signaling. Fast time course studies of filopodial dynamics 
showed that the rapid filopodial elongation seen after different treatments was achieved mainly 
by changes in two parameters of filopodial motility: increases in the extension rate and in the 
time that individual filopodia spend extending. By employing drugs that interfere with actin 
polymerization and myosin II activity, we further provide evidence that filopodial elongation 
 31
seen after inhibition of PI-3K is mainly due to an increase in actin polymerization at the barbed 
end, and not through inhibition of retrograde actin flow. Because filopodial elongation and a 
decrease in the rate of neurite outgrowth seen after inhibition of PI-3K in this study are similar to 
growth cone behavior observed at “decision points” during pathfinding in vivo (Taghert et al., 
1982; Tosney and Landmesser, 1985; Holt, 1989), these data suggest that signaling through PI-
3K could be of critical importance for growth cone motility, and that a lack of stimulation or 
inhibition of the PI-3K pathway could result in slow-down and search behavior in advancing 
neurites. 
 
Methods and Materials 
Neuronal culture and image acquisition 
 Identified B5 neurons were dissected from Helisoma trivolvis buccal ganglia and plated 
for neuronal culture. Neurons used for filopodial experiments were plated on poly-L-lysine 
(hydrobromide, MW 70,000-150,000, 0.25mg/ml; Sigma, St. Louis, MO) coated glass cover 
slips that were glued to the bottom of 35 mm cell culture dishes (Falcon 1008).  Neurons used for 
outgrowth experiments were plated onto either the same glass dishes described above, or onto 
poly-L-lysine coated plastic cell culture dishes as described in Trimm and Rehder (2004). Cells 
were kept at room temperature and used 24-48 hours after plating.  Neurons were grown in 
conditioned medium (CM) prepared by incubating two snail brains per milliliter in defined 
medium (DM) for 3-4 days. DM was produced by dilution of Leibowitz L-15 medium (Gibco 
#41300, Grand Island, NY) with distilled water to obtain the appropriate ionic composition and 
contained final concentrations of: 46 mM NaCl, 1.8 mM KCl, 1.5 mM MgCl2, 4.1 mM CaCl2, 10 
mM HEPES, 50 µg gentamycin/ml, 0.15 mg glutamate/ml in distilled water (pH=7.3).  Growth 
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cones were viewed through 100x oil immersion objectives on either an Axiovert (Carl Zeiss, 
Thornwood, NY) or a Sedival (aus Jena, Germany) microscope.  Neurite outgrowth was imaged 
through a 40x objective on a Sedival microscope. Images were captured with a cooled CCD 
camera (CH250, Photometrics, Tucson AZ) or a regular CCD camera (Model: C-72, MIT Dage, 
Michigan City, IN). Images were digitized on a frame grabber (Scion LG-3, Scanalytics, Fairfax, 
VA) and analyzed with “Scion Image” software (Scion Corporation; Frederick, Maryland) on a 
Power Macintosh (Apple Computer, Cupertino, CA) or a Compaq Presario (Hewlett-Packard 
Company, Palo Alto, CA). 
 
Pharmacological agents 
LY 294002 (PI-3K inhibitor), PD 98059 (MAP kinase kinase inhibitor), Akt inhibitor, 
blebbistatin (nonmuscle myosin II ATPase inhibitor), and cytochalasin B (actin polymerization 
inhibitor) were dissolved in DMSO to obtain stock concentrations of 20, 50, 45, 50 mM and 60 
µM respectively. Wortmannin, another PI-3K inhibitor, was dissolved in methanol to a stock 
concentration of 1 mM. The Rho-kinase inhibitor Y27632 was dissolved in water to a stock 
concentration of 10 mM. All agents were purchased from Calbiochem (San Diego, CA). 
 
Design and analysis of filopodial experiments 
Observation of growth cone behavior, specifically, changes in filopodial length and 
filopodial number, was performed at defined times before and after the addition of 
pharmacological agents, which were added to the dish through a complete medium exchange.  
Immediately before each experiment, drugs were premixed in 2 mL of L-15 medium to obtain 
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final concentrations. Control experiments were performed for each of the solvents used in the 
reconstitution of pharmacological agents and, in each case, the final solvent concentration did 
not exceed 0.2%. At these concentrations, the solvents had no significant effect on filopodia. 
Images were captured before (-5 and 0 min) and at defined times after (2, 5, 10, 15, 20, and 30 
minutes) a complete medium exchange, which introduced the experimental condition.  
Digitized images of growth cones were analyzed by tracking all filopodia from image to 
image in previously defined intervals, and by measuring the length of filopodia from their base to 
their tip.  The filopodial base was defined as the transition point where the lamellipodial 
peripheral domain meets the organelle rich central domain of the growth cone. Filopodial length 
was measured from phase contrast images using the software package “Scion Image.” All 
filopodia on a growth cone were measured and those values were averaged to result in a measure 
of ‘mean filopodial length’ for each growth cone. These values were expressed as a percentage 
change normalized to the time point t = 0 just before any drug treatment to compensate for the 
fact that individual growth cones varied in size and filopodial length.  
Fast time-course experiments were performed on single growth cones by tracking 
individual filopodia from image to image as previously described (Van Wagenen et al., 1999). 
Images were acquired every 30 seconds during 7 minutes before treatment (Pre) and 10 minutes 
after treatment (Post). This experimental design allows for determination of the parameters of 
filopodia dynamics, such as the time a filopodium spends extending, retracting, or being stable. 
Moreover, the extension and retraction rates of individual filopodia can be measured with this 
approach. Filopodia were classified as extending or retracting if their individual filopodial length 
increased or decreased by 0.4 µm in 30 seconds. Filopodia that did not meet this criterion were 
considered as stable. Filopodia extension and retraction rates were expressed in µm/30 sec. 
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Design and analysis of neurite outgrowth experiments 
 Images of neurons were taken at 20 minutes intervals for a total of 2 hours per 
experiment as previously described (Trimm and Rehder, 2004). Neurite outgrowth was 
determined by measuring neurite length starting from a fixed point in the dish (e.g. soma) and 
measuring the distance to the growth cone’s central domain using the software package “Scion 
Image.” Neurites that advanced less than 6 µm during the control period (one hour before 
treatment) or that fasciculated with other neurites during the experiment were excluded from 
analysis. Outgrowth during the first hour of treatment following drug addition was measured by 
subtracting neurite length at t = 0 from t = 60. Outgrowth during the second hour of treatment 
following drug addition was measured by subtracting neurite length at t = 60 from t = 120. In 
order to introduce the experimental condition, 0.2 mL of conditioned medium was removed from 
the dish, a drug was premixed in this volume, and the 0.2 mL was subsequently added back to 
the dish to obtain the final concentration.  Solvents used in the reconstitution of pharmacological 
agents were tested by themselves in control experiments and had no significant effect on neurite 
outgrowth.  
   
Calcium imaging 
 Calcium imaging was performed as described previously (Rehder and Cheng, 1998; Van 
Wagenen and Rehder, 1999).  Briefly, Helisoma B5 neurons were pressure injected (Picospritzer; 
General Valve Corp., Fairfield, NJ) with the calcium indicator dye, Fura-2 pentapotassium salt (10 
mM in water; Molecular Probes, Eugene, OR).  Cells were used 20-30 minutes after injection in 
order to allow for the calcium indicator to diffuse.  Fura-2 was excited at two excitation wavelengths 
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(340±10 nm and 380±10 nm) and after calibration, the ratio of the fluorescent images captured was 
converted into an estimated [Ca2+]i according to Grynkiewicz et al. (1985).   
 
Actin labeling and analysis of actin fluorescence  
 Growth cones were fixed and stained according to Cohan et al. (2001) with the variation that 
rhodamine phalloidin was used (Molecular Probes) at a concentration of 0.165 µM. Growth cones 
were viewed through a 100x oil immersion objective on a Zeiss Axiovert inverted microscope 
equipped with a rhodamine filter set (Omega Optical, Brattleboro, VT). Images were acquired using 
a cooled Photometrics CCD camera, and stored on a Macintosh computer. A camera exposure time 
of 200 ms was used for all images.  Image intensity was analyzed with Scion Image software (Scion 
Corporation) and two measurements were taken to quantify f-actin content in growth cones.  To 
calculate the mean fluorescent intensity of f-actin in the growth cone’s p-region, a line was drawn 
outlining the lamellipodial region and the measured fluorescence averaged. The fluorescent intensity 
of actin bundles forming the core of filopodia was analyzed according to Cohan et al. (2001).  
Briefly, a line was drawn across individual actin bundles within the middle of the lamellipodium.  
The peak intensities for each bundle (the average of 3 pixels for each bundle) were determined and 
this procedure repeated for at least 5 filopodia per growth cone, except when that was impossible 
due to loss of filopodia (condition with 500 nM Cytochalasin B). These values were then expressed 
as an average peak intensity for each growth cone. Staining was done in parallel for different 
experimental conditions to minimize differences in staining intensity between dishes. 
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Statistical analysis 
 For filopodial experiments, significance between conditions was determined by performing 
an analysis of variance (1-way ANOVA or ANOVA with time as repeated measures), and with a t-
test for dependent and independent samples, with SuperANOVA (Abacus Concepts, Berkeley, CA). 
Fisher’s protected least significant difference (PLSD) test was used for post-hoc tests of statistical 
significance. For neurite outgrowth, fast time-course and actin labeling experiments, significance 
between conditions was determined by performing a Student’s t-test (for unpaired or paired samples) 
with Excel (Microsoft; Redmond, WA). Significant differences are indicated as: *p ≤ 0.05, **p ≤ 
0.01, ***p ≤ 0.001. 
 
Results 
PI-3K inhibition induces filopodial elongation and a slow-down in the rate of neurite advance  
To investigate the effect of PI-3K activity on growth cone motility, B5 neurons were 
treated with two specific PI-3K inhibitors, wortmannin and LY 294002. Treatment with LY 
294002 (25 µM) resulted in filopodial elongation as early as five minutes after addition of the 
drug, with maximal overall filopodial elongation of 37.6 ± 6.1% reached after 20 min (Fig. 2.1A 
and 1B) (see Supplemental time-lapse movie). This elongation effect was highly significantly 
when compared to the control condition (p ≤ 0.001), in which solvent alone (DMSO 0.125%) 
was applied. Interestingly, the number of filopodia on a given growth cone, another parameter of 
growth cone morphology, was not affected by LY 294002 (p = 0.70) (Fig. 2.1C). To confirm 
independently the effect of PI-3K inhibition on growth cone morphology, neurons were treated 
with a second PI-3K inhibitor, wortmannin (Wort, 2 µM). At this concentration, the overall 
filopodial length increased significantly by 46.6 ± 9.6% after 20 min (p ≤ 0.001) compared to the  
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Figure 2.1: Inhibition of PI-3K results in an increase in filopodial length by increasing the 
time filopodia spent extending and the filopodial extension rate, but has no effect on 
filopodial number. 
(A) Phase-contrast images of a representative B5 growth cones 5 minutes before (pre) and 9 
minutes after treatment with the PI-3K inhibitor, LY 294002 (25 µM). Note that a majority of 
filopodia elongate (representative filopodia are indicated with an arrow). Scale bar = 12µm. (see 
Supplemental time-lapse movie of this growth cone). (B) Treatment of B5 growth cones with LY 
294002 (25 µM) caused a significant increase in overall filopodial length as early as 5 min after 
addition of the drug. Exposure of growth cones to DMSO (0.125%), the solvent in which LY 
294002 was dissolved, had no effect on filopodial length (p = 0.70). The effect of LY 294002 
was significantly different from the control condition (p ≤ 0.001), as indicated in parentheses 
behind the treatment group. PI-3K inhibition with a second PI-3K inhibitor, wortmannin (2 µM), 
also caused a rapid significant increase in overall filopodial length when compared to its 
methanol control (0.2%) (p ≤ 0.001). (C) The number of filopodia on a given growth cone was 
not affected by either LY 294002 (25 µM) or wortmannin (2 µM) treatment and there also was 
no significant difference between the two drug treatments (p = 0.644). (D) Inhibition of PI-3K 
with 25 µM LY 294002 resulted in a significant increase in the time filopodia spent extending in 
the first five minutes following drug addition (Post) in comparison to 7 min prior to drug 
addition (Pre). The time spent stable and retracting were not significantly affected by LY 294002 
(25 µM) treatment (p = 0.12 and p = 0.36 respectively). (E) Treatment with 25 µM LY 294002 
caused a significant increase in the filopodial extension rate in comparison to its control (Pre, 7 
min prior to drug addition) (p ≤ 0.01). Filopodial retraction rate was not affected by LY 294002 
(25 µM) treatment (p = 0.45). 
For all experiments the number of growth cone studied per condition is given as ‘n’ and listed 
behind each experimental condition. Statistical significance between conditions is symbolized by 
asterisks as follows: *P ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. 
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solvent control (Fig. 2.1B). Note that the filopodial elongation induced by LY 294002 and 
wortmannin were not significantly different (p = 0.98), suggesting that the two inhibitors blocked 
PI-3K to a similar degree when used at these concentrations. Consistent with the observation 
made with the other PI-3K inhibitor (LY 294002), treatment with wortmannin also had no 
significant effect on filopodial number (p = 0.64) (Fig. 2.1C).  
 Growth cone filopodia frequently switch between episodes of extension and retraction within 
seconds. Whereas the measurements above captured the average length and number of filopodia at 
fixed time points that were separated by several minutes, we next wanted to investigate the dynamic 
process of filopodial elongation in more detail. Filopodial length changes can be explained by 
underlying changes in dynamic filopodial parameters, such as the amount of time individual 
filopodia spend extending, retracting or not moving (stationary), as well as the rates at which 
filopodia extend and retract. To investigate which parameters of filopodial dynamics were affected 
to explain the filopodial elongation observed after inhibition of PI-3K, individual filopodia on single 
growth cones were tracked every 30 sec during a 7 min pretreatment period (Pre), and during the 
initial 4-5 minutes after treatment that included the phase of rapid filopodial elongation (Post). 
Treatment with LY 294002 significantly increased the time that filopodia spent extending from 39.5 
± 1.6 % before treatment to 52.0 ± 3.6 % after treatment (p ≤ 0.05) (Fig. 2.1D). The times filopodia 
were stationary and spent retracting were not affected (p = 0.12 and p = 0.36 respectively) (Fig. 2.1 
D). The filopodial extension rate was significantly increased from 1.26 ± 0.06 µm/30 sec  before 
treatment (Pre) to 1.72 ± 0.1 µm/30 sec after treatment with LY 294002 (p ≤ 0.01) (Fig. 2.1E). 
Treatment with the PI-3K inhibitor did not affect the filopodial retraction rate (p = 0.45) (Fig. 2.1E). 
These results suggested that the overall filopodial elongation seen in response to PI-3K inhibition 
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resulted from the combination of an increase in the extension rate and the time that filopodia spent 
extending.  
 We next investigated whether PI-3K inhibition would also affect neurite outgrowth. 
Indeed, treatment with LY 294002 significantly reduced the neurite outgrowth rate from 18.2 ± 
1.7 µm in the hour prior to treatment to 8.5 ± 2.6 µm (p ≤ 0.001) in the first hour after treatment 
(Fig. 2.2). A further significant decrease in outgrowth to 3.2 ± 1.7 µm resulted in the second hour 
of treatment. Taken together, these results suggested that a decreased stimulation, or inhibition of 
the PI-3K pathway, could serve as an acute slow-down and search signal for migrating growth 
cones.  
 
MEK, Akt and ROCK regulate filopodial dynamics and neurite outgrowth 
 To investigate the pathway by which PI-3K might regulate growth cone motility, we 
pharmacologically inhibited major targets downstream of PI-3K with the assumption that their 
inhibition should mimic the effect of PI-3K inhibition and result in filopodial elongation and/or a 
slow down in neurite outgrowth.  PI-3K has a double enzymatic activity, acting as a protein 
kinase and a lipid kinase (Krasilnikov, 2000; Cantley, 2002) (Fig. 2.3). Therefore, we wanted to 
investigate which of the two activities might be involved in controlling filopodial dynamics and 
neurite outgrowth. 
 We first inhibited Akt and ROCK, which are activated by the lipid kinase activity of PI-
3K. Akt was blocked with the Akt inhibitor (80 µM) and ROCK was inhibited with Y27632 (10 
µM) (Fig. 2.3). Treatment with Akt inhibitor and Y27632 increased filopodial length by 28.4 ± 
2.4% and 23.6 ± 2.4% respectively in comparison to the control condition (p ≤ 0.001) (Fig.  
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Figure 2.2: Inhibition of PI-3K results in a slow-down of neurite outgrowth.  
Inhibition of PI-3K with 25 µM LY 294002 resulted in a significant decrease in neurite 
outgrowth in the first hour following drug addition (p ≤ 0.001).  A further significant decrease 
was seen in the second hour following drug addition (p ≤ 0.001 as compared to the hour prior to 
drug addition).  Note that addition of the solvent control (DMSO) by itself had no effect on 
neurite outgrowth. 
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Figure 2.3: Investigated signaling pathways by which PI-3K may regulate growth cone 
dynamics. 
PI-3K is activated by multiple effectors. The PI-3K signaling pathway is bifurcated and has two 
branches, resulting from its lipid- and protein kinase activities. Through its lipid kinase activity, 
PI-3K phosphorylates phosphatidylinositol (PI) and its phosphorylated derivatives. Then 
phosphoinositides activate the RhoA/ROCK pathway, and the phosphoinositide-dependent 
kinase (PDK), which in turn activates Akt. Through its protein kinase activity (in gray), PI-3K 
binds directly to Ras and Rac-Cdc42, leading to the activation of MEK. Kinases investigated in 
this study are in bold typeface and underlined. Inhibitors are indicated in italics. 
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Figure 2.4: Regulation of filopodial dynamics by Akt and ROCK. (A-F)  
The involvement of the lipid kinase activity of PI-3K was tested by strategically inhibiting key 
kinases downstream of PI-3K activity (see Fig. 2.3). (A, B) Two targets of the PI-3K lipid 
activity, namely Akt and ROCK, were inhibited with Akt inhibitor, and with Y27632 
respectively. (A) Both Akt inhibitor (80 µM) and ROCK inhibitor, Y27632 (10 µM), 
significantly increased overall filopodial length in comparison to their respective control 
conditions, 0.175% DMSO and 0.1% water (dH2O) (both p ≤ 0.001). (B) Filopodial number was 
not significantly altered by the inhibition of Akt with Akt inhibitor (80 µM) (p = 0.44) or by the 
inhibition of ROCK with Y27632 (10 µM) (p = 0.07) when compared to controls. (C) Inhibition 
of Akt with Akt inhibitor (80 µM) resulted in a significant increase in the time filopodia spent 
extending in the first five minutes following drug addition (Post) compared to the 7 min control 
time window prior to drug addition (Pre) (p ≤ 0.05). The times spent stable and retracting were 
not significantly affected by Akt inhibitor (80 µM) treatment (p = 0.05 and p = 0.85 
respectively). (D) Treatment with 80 µM Akt inhibitor caused a significant increase in filopodial 
extension rate compared to control (Pre, 7 min prior to drug addition) (p ≤ 0.05).  The filopodial 
retraction rate was not affected by Akt inhibitor (80 µM) (p = 0.24). (E) Inhibition of ROCK 
with Y27632 (10 µM) resulted in a significant increase in the time filopodia spent extending (p ≤ 
0.01), as well as a significant decrease in the time filopodia spent being stable (p ≤ 0.05). The 
time spent retracting was not significantly affected by Y27632 (10 µM) treatment (p = 0.09). (F) 
Treatment with 10 µM Y27632 caused a significant increase in filopodial extension and 
retraction rates compared to controls (Pre, 7 min prior to drug addition) (p ≤ 0.01 and p ≤ 0.05 
respectively). 
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2.4A). Filopodial number was not affected by these treatments (p = 0.44 and p = 0.07 
respectively) (Fig. 2.4B). 
Next, we investigated which parameters of filopodial dynamics were affected by 
inhibiting targets of the lipid kinase pathways of PI-3K. Therefore, we monitored filopodial 
dynamics in fast time-course experiments as described earlier. Treatment with Akt inhibitor 
increased significantly the time filopodia spent extending from 32.9 ± 1.6% before treatment 
(Pre) to 42.3 ± 2% after treatment (Post) (p ≤ 0.05) (Fig. 2.4c). The times filopodia were 
stationary and spent retracting were not affected by Akt inhibitor (p = 0.05 and p = 0.85 
respectively) (Fig. 2.4C). The filopodial extension rate was also significantly increased from 1.04 
± 0.04 µm/30 sec before treatment (Pre) to 1.33 ± 0.08 µm/30 sec after treatment (p ≤ 0.05; Fig.  
2.4D). The ROCK inhibitor, Y27632 induced a significant increase in the time filopodia spent 
extending from 39.3 ± 1.2% before treatment (Pre) to 51.2 ± 3% after treatment (Post) (p ≤ 0.01; 
Fig. 2.4E). The time filopodia were stationary was significantly decreased from 26.9 ± 1.4% to 
19.8 ± 2.1% (p ≤ 0.05) as compared to controls (Pre), whereas the time filopodia spent retracting 
was not affected (p = 0.09) (Fig. 2.4E). Inhibition of ROCK also increased both the extension 
and the retraction rates from 1.34 ± 0.07 µm / 30 sec to 1.73 ± 0.08 µm / 30 sec, and from 1.35 ± 
0.05 µm / 30 sec to 1.51 ± 0.03 µm / 30 sec  respectively (p ≤ 0.01 and p ≤ 0.05) (Fig. 2.4F). 
The effect of inhibition of Akt and ROCK on neurite outgrowth was studied next. When 
Akt was inhibited, neurite outgrowth was not affected in the first hour following drug addition 
(16.2 ± 2.8 µm in the hour prior to drug addition and 13.6 ± 3.2 µm in first hour following drug 
addition; Fig. 2.5A). However, in the second hour following drug addition, neurite outgrowth 
was significantly slowed to 6.7 ± 3.0 µm (p ≤ 0.001 as compared to the hour prior to drug 
addition). When ROCK was inhibited with Y27362 neurite outgrowth also was not affected in  
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Figure 2.5: Regulation of neurite outgrowth by Akt and ROCK. 
(A) Inhibition of Akt with Akt inhibitor (80 µM) did not significantly affect neurite outgrowth in 
the first hour following drug addition. However, neurite outgrowth was slowed significantly in 
the second hour following drug addition (p ≤ 0.001). (B) Inhibition of ROCK with 10 µM 
Y27362 did not significantly affect neurite outgrowth in the first hour after drug addition.  
However, neurite outgrowth was slowed significantly in the second hour following drug addition 
(Student’s t-test, **p ≤ 0.01). 
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the first hour following drug addition (20.5 ± 2.1 µm in the hour prior to drug addition and 18.8 
± 2.6 µm in first hour following drug addition; Fig. 2.5B). However, in the second hour 
following drug addition, neurite outgrowth was significantly decreased to 12.0 ± 2.6 µm (p ≤ 
0.01 as compared to the hour prior to drug addition). Taken together, these results are consistent 
with the idea that the lipid kinase activity of PI-3K is involved in controlling filopodial dynamics 
and neurite outgrowth through Akt and ROCK. To determine whether the decreases in neurite 
outgrowth rates observed in the first or second hour after the inhibition of PI-3K, Akt and ROCK 
were due to an adverse effect of the long-term exposure of the drugs on filopodial dynamics, we 
measured the dynamic parameters of filopodia after 2 hrs of treatment with LY 294002, Akt 
inhibitor and Y27632 (Table 2.1). 
A comparison of filopodial behaviors (time filopodia spend extending, stationary, or 
retracting) revealed that there were no significant differences between these filopodial behaviors 
before and two hours after treatment, with the exception of the Akt inhibitor resulting in 
filopodia spending more time retracting, and Y 27632 resulting in filopodia spending less time 
stationary and more time retracting (Table 2.1). Moreover significant long term effects of these 
drugs on filopodial extension and retraction rates when comparing these parameters before and 
two hours after treatment. These results suggest that filopodia remained motile during long-term 
drug treatment and that the decrease in neurite outgrowth rate observed in response to LY 
294002, Akt inhibitor and Y27632 treatments likely results from mechanisms other than 
affecting filopodial dynamics. We next inhibited MAP kinase kinase (MEK), which is activated 
by the protein kinase activity of PI-3K (Fig. 2.3). After treatment with specific MEK inhibitor 
PD 98059 (40 µM), the filopodial length increased by 23.0 ± 3.1% (Fig. 2.6A), and this 
elongation was significant when compared to the control group (p ≤ 0.001), which showed no  
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Table 2.1: Comparison of filopodial parameters before and two hours after drug 
treatments. 
*p ≤ 0.05 compared to control (Pre). 
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1.34 ± 0.07
1.45 ± 0.14
1.35 ± 0.05
1.53 ± 0.14
1.04 ± 0.04
1.26 ± 0.11
1.02 ± 0.07
1.06 ± 0.07
1.26 ± 0.06
1.39 ± 0.13
1.30 ± 0.04
1.49 ± 0.15
Rate (µm/30 s)
Extension (pre)
Extension (2 hr post)
Retraction (pre)
Retraction (2 hr post)
39.3 ± 1.2
38.9 ± 2.7
26.9 ± 1.4
19.4 ± 3.1*
33.8 ± 2.1
41.6 ± 0.5*
32.9 ± 1.6
35.6 ± 5.2
39.8 ± 2.0
28.2 ± 6.6
27.3 ± 1.6
36.2 ± 2.9*
39.5 ± 1.6
42.5 ± 5.0
26.4 ± 3.8
23.1 ± 4.8
34.1 ± 3.0
34.4 ± 2.3
% Time spent
Extending (pre)
Extending (2 hr post)
Stable (pre)
Stable (2 hr post)
Retracting (pre)
Retracting (2 hr post)
ROCK
Inhibition
Akt
Inhibition
PI-3K
Inhibition
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Figure 2.6: Regulation of growth cone filopodia by MEK inhibition. 
(A) Treatment of B5 neurons with the MEK inhibitor PD 98059 (40 µM) to inhibit the protein 
kinase branch of PI-3K caused a significant overall increase in filopodial length as early as 5 min 
after addition of the drug. PD 98059 was washed out in an exchange with defined medium after 
15 min of treatment. Exposure of growth cones to DMSO (0.08%), the solvent in which PD 
98059 was applied, had no effect on filopodial length, and the treatment group was significantly 
different from the control (p ≤ 0.001). (B) Treatment with PD 98059 (40 µM) had no significant 
effect on filopodial number when compared to the control group (p = 0.50). (C) The time 
filopodia spend extending significantly increased within the first five minutes following PD 
98059 (40 µM) addition in comparison to control (7 min before drug addition) (p ≤ 0.05). No 
differences were observed in the times filopodia spent stable and retracting (p = 0.21 and p = 
0.50 respectively). (D) The filopodial extension rate was significantly increased after MEK 
inhibition with PD 98059 (40 µM) in comparison to control (before drug addition, “Pre”) (p ≤ 
0.05). The filopodial retraction rate was not affected (p = 0.98). 
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filopodial length change. The number of filopodia on a growth cone was not affected by the 
inhibition of MEK (p = 0.50) (Fig. 2.6B), which was consistent with the lack of effect on 
filopodial number after inhibiting PI-3K. It is important to note that PD 98059 started to 
crystallize after 15 minutes of application, at which time the drug was washed out through an 
exchange with defined medium. Thus time points after the initial ten minutes have to be taken 
with caution, although a return of filopodial length towards pretreatment levels observed after 
washout of the drug indicated some reversibility of the drug treatment. Note that the tendency to 
crystallize precluded studies on neurite outgrowth employing this drug.  
The investigation of dynamic changes in filopodial length revealed that PD 98059 
significantly increased the time that filopodia spent extending from 37.4 ± 1.6 % before 
treatment to 44.9 ± 2.2 % after treatment (p ≤ 0.05) (Fig. 2.6C). The time filopodia were 
stationary or spent retracting was not affected (p = 0.21 and p = 0.50 respectively) (Fig. 2.6C). 
The filopodial extension rate was significantly increased from 1.39 ± 0.12 µm/30 sec before 
treatment (Pre) to 1.87 ± 0.12 µm/30 sec after MEK inhibition (p ≤ 0.05), whereas the filopodial 
retraction rate was not affected (p = 0.98) (Fig. 2.6D). These results suggested that MEK activity 
has a strong effect on filopodial length and might serve as a regulator of actin dynamics in 
Helisoma growth cones. 
 
Both activities of PI-3K act together to regulate filopodial dynamics 
Because the inhibition of individual targets of the lipase and kinase activities of PI-3K 
(Akt, ROCK, and MEK) each induced a smaller overall effect on filopodial elongation (~ 20-
28%) than seen after PI-3K inhibition itself (~ 46%), we next wanted to investigate if MEK, Akt, 
and ROCK might interact to affect filopodial dynamics. To test this possibility, we treated B5 
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neurons with various combinations of the following inhibitors: MEK inhibitor PD 98059 (40 
µM), Akt inhibitor (80 µM), and ROCK inhibitor Y27632 (10 µM). Interestingly, filopodia 
elongated by 42.3 ± 6.0% after 15 min of combined treatment with ROCK and MEK inhibitors, 
and by 46.6 ± 5.2% when all three inhibitors were combined. Whereas these values were not 
significantly different from each other and from treatment with the PI-3K inhibitor itself, they 
were significantly larger than those obtained when each inhibitor was applied separately (Fig. 
2.7). Note that there was no additive effect when the two kinases in the lipid kinase branch (Akt 
and ROCK) were inhibited simultaneously (Fig. 2.7).  
 
Growth cone behavior is not mediated by altering [Ca2+]i  
PI-3K and its downstream targets have been shown to regulate the intracellular calcium 
concentration ([Ca2+]i) in different systems  (Blair et al., 1999; Macrez et al., 2001; Singleton and 
Bourguignon, 2002). An elevation in [Ca2+]i in B5 growth cones results in filopodial elongation 
(Rehder and Kater, 1992; Cheng et al., 2002) and a slow down in neurite outgrowth (Cohan et 
al., 1987; Mattson and Kater, 1987). Thus it was important to investigate whether the filopodial 
elongation observed after inhibition of the PI-3K signaling pathway was actually due to an 
increase in [Ca2+]i resulting from the pharmacological treatment or if the effect was Ca2+-
independent. Employing the calcium indicator dye, fura-2, we detected no increase in the [Ca2+]i 
in B5 growth cones after inhibition of PI-3K with wortmannin (2 µM), of Akt with Akt inhibitor 
(80 µM) and of ROCK with Y27632 (10 µM) (Fig. 2.8). However, because the crystals that 
formed 15 minutes after treatment with MEK inhibitor PD 98059 (40 µM) were autofluorescent, 
we were unable to measure the [Ca2+]i for this condition during the second half of the 
experiment. In the first 10 minutes before crystal formation, however, no increase in [Ca2+]i was 
 57
detected. Depolarization of B5 neurons with a high K+ containing medium (34 mM KCl) resulted 
in a significant increase in [Ca2+]i in B5 growth cones from 59 ± 2 nM at rest to maximal levels 
of 128 ± 5 nM five minutes after treatment (p ≤ 0.001) (Fig. 2.8), demonstrating that the calcium 
indicator fura-2 calcium was functional, and that a high K+ medium elevated [Ca2+]i to levels 
consistent with observations in previous studies on the same cell type (Rehder and Cheng, 1998).  
 
PI-3K regulates actin dynamics  
 Filopodia are composed of bundles of filamentous (f-) actin (Gordon-Weeks, 
1987) and the barbed ends, where net addition of monomeric actin occurs, are located towards 
the filopodial tip. Theoretically, filopodial elongation could result from: (i) an increase in actin 
polymerization at the barbed end, (ii) a decrease in retrograde flow of f-actin without affecting 
the normal net addition of monomeric actin at the barbed end, or (iii) a combination of both (Fig. 
2.9A). In initial experiments we wanted to obtain a qualitative assessment of the contribution of 
these mechanisms to filopodial length changes in untreated growth cones. Blebbistatin (Bleb) 
was employed to inhibit the ATPase activity of nonmuscle myosin II (Straight et al., 2003) and 
thereby block its potential contribution to the retrograde f-actin flow (Fig. 2.9A). Addition of 
blebbistatin (100 µM) resulted in a gradual increase in filopodial length over time which reached 
55.5 ± 17.9% after 30 min of treatment when compared to its control (DMSO) (p ≤ 0.01) (Fig. 
2.9B), consistent with the notion that barbed end addition would continue in the absence of 
retrograde flow, creating a net increase in f-actin filament length (Fig. 2.9A). Cytochalasin B 
(Cyto B) was used to interfere with the addition of monomeric actin to the barbed end of f-
actin.While Cyto B has been shown to result in the depolymerization of f-actin (Forscher and 
Smith, 1988), we used Cyto B at a concentration (30 nM) that had no net effect on overall 
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Figure 2.7: Both activities of PI-3K interact to regulate filopodial dynamics.  
B5 neurons were treated with the following inhibitors either separately or in combinations, and 
filopodial elongation was assessed 15 min after treatment. Treatment with PI-3K inhibitor LY 
294002 (25 µM), Akt inhibitor (80 µM), ROCK inhibitor Y27632 (10 µM), and MEK inhibitor 
PD 98059 (40 µM) induced overall filopodial elongation of 34.8 ± 7.9%, 25.7 ± 3.5%, 23.6 ± 
2.3%, and 18.7 ± 3.4%, respectively. Filopodia elongated by 42.3 ± 6.0% when one kinase each 
of the lipid- and protein kinase branch was inhibited together (ROCK and MEK inhibitors). 
Simultaneous inhibition of Akt, ROCK and MEK resulted in filopodial elongation of 46.6 ± 
5.2% and had no significant additional effect over inhibiting ROCK and MEK simultaneously. 
The combinatorial effects were not significantly different from treatment with the PI-3K 
inhibitor itself (p = 0.08), but significantly larger than when Akt inhibitor (80 µM) (p ≤ 0.01), 
ROCK inhibitor, Y27632 (10 µM) (p ≤ 0.001), and MEK inhibitor, PD 98059 (40 µM) (p ≤ 
0.001) were applied separately. Note that there was no additive effect when the two kinases in 
the lipid kinase branch (Akt and ROCK) were inhibited simultaneously. The control condition 
denotes a final concentration of 0.125% DMSO (as used for LY 294002 (25 µM)), and this 
control was not significantly different from controls for the other solvents used (not shown). 
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Figure 2.8: Growth cone behavior was not mediated by altering [Ca2+]i. 
Measurements of [Ca2+]i with the Ca2+ indicator fura-2 in response to various treatments used in 
this study show that the inhibition of PI-3K and its downstream targets had no significant effect 
on [Ca2+]i. A control treatment with high KCl (34 mM) increased [Ca2+]i to maximum levels of  
128 nM after 5 min (p ≤ 0.001). 
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Figure 2.9: Filopodial elongation resulting from PI-3K inhibition requires actin 
polymerization.  
(A) Model of filopodial length changes. Filopodial length is mainly regulated by actin 
polymerization/depolymerization events at the barbed end and the retrograde flow by which f-
actin is transported centrally (left). The curved arrow indicates actin polymerization onto the 
barbed (+) end of f- actin, which would result in filopodial elongation. Arrows pointing to the 
right symbolize actin polymerization and arrows pointing to the left symbolize retrograde flow. 
The middle panel shows the net effect of various experimental treatments on overall filopodial 
length. The right panel shows the hypothesized relative contributions (indicated by the length of 
the arrows) of actin polymerization and retrograde flow on filopodial length under these 
experimental conditions. See text and (B) for details. (B) Inhibition of ATPase activity of 
nonmuscle myosin II with blebbistatin (100 µM) resulted in a gradual increase in filopodial 
length over time that was significant when compared to its control (DMSO) (p≤ 0.01). The 
inhibitor of actin polymerization, cytochalasin B, at the low concentration of 30 nM had no net 
effect on filopodial length (p = 0.67). Combined treatment with cytochalasin B (30 nM) and 
blebbistatin (100 µM) blocked filopodial elongation induced by blebbistatin treatment alone (p ≤ 
0.05). Inhibition of PI-3K with wortmannin (2 µM) resulted in net filopodial elongation, and this 
effect was of a similar magnitude as observed with blebbistatin treatment. Wortmannin (2 µM) in 
the presence of blebbistatin (100 µM) induced a larger effect on filopodial elongation when 
compared to wortmannin and blebbistatin applied separately (p ≤ 0.001). Filopodial elongation 
observed after wortmannin treatment was blocked by 10 minutes preincubation with 30 nM 
cytochalasin B (p ≤ 0.01). (C) Effect on filopodial length from (B) after 10 minutes of treatment. 
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filopodial length (Fig. 2.9 and Geddis et al., 2004). This result suggested that barbed end addition 
was slowed by Cyto B to a degree that it was equal and opposite to the effect of retrograde flow. 
When neurons were incubated in blebbistatin plus Cyto B the change in filopodial net length seen 
with blebbistatin treatment alone was significantly blocked (p ≤ 0.05) (Fig. 2.9B and C), suggesting 
that when plus-end addition cannot occur, the filopodial elongation that is seen with blebbistatin 
alone is blocked, demonstrating the important role of actin polymerization for filopodial elongation.  
 To confirm that the total f-actin content was not affected by the treatment with 30 nM Cyto 
B, we employed a fluorescently labeled mushroom toxin, rhodamine phalloidin, which binds to f-
actin. Overall, growth cones treated with 30 nM Cyto B for 30 minutes appeared no different from 
control growth cones (Fig. 2.10A). However, treatment with a higher concentration of Cyto B (500 
nM) resulted in an obvious decrease in f-actin staining and a loss of filopodia (Fig. 2.10A). 
Quantification of the intensity of f-actin staining within the lamellipodial P-region of growth cones, 
however, revealed a small decrease in the intensity of staining in growth cones treated with 30 nM 
Cyto B when compared to control growth cones (from 79.4 ± 4.8 to 65.1 ± 4.4 fluorescence units; 
Fig. 2.10B; p ≤ 0.05, t-test). Treatment with 500 nM Cyto B showed a large reduction in f-actin 
staining in the P-region (to 37.7 ± 3.0) (Fig. 2.10A and B; p ≤ 0.001, t-test).  When f-actin content of 
individual f-actin bundles (forming the core of filopodia) was measured (see Methods for details), no 
difference between control growth cones and those treated with 30 nM Cyto B was found (Fig. 
2.10C; p = 0.23, t-test). Growth cones treated with 500 nM Cyto B, however, showed a significant 
loss in actin bundle intensity (from 110.0 ± 4.4 to 58.2 ± 3.9; Fig. 2.10C; p ≤ 0.001, t-test). These 
results suggested that although 30 nM Cyto B slightly reduced the amount of f-actin within the P-
region of the growth cone, the f-actin content within filopodia was not measurably affected.  
 We next wanted to use the tools developed above to investigate whether PI-3K inhibition 
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Figure 2.10: A low concentration of cytochalasin B (30 nM) does not affect filopodial actin 
bundles, but slightly reduces overall f-actin staining intensity within the p-region. 
Growth cones received one of three treatments (L-15 medium exchange (Control), 30 nM Cyto B 
in L-15, or 500 nM Cyto B in L-15) for 30 minutes and were subsequently fixed in 
parformaldehyde/glutaraldehyde and reacted with rhodamine phalloidin. (A) Growth cones that 
received the 30 nM Cyto B treatment look indistinguishable from control growth cones regarding 
overall morphology, as well as number and intensity of fluorescent F-actin bundles visible in the 
growth cone. Note the noticeable loss of f-actin staining and filopodia in growth cones treated 
with 500 nM Cyto B.  Scale: 10 µm. (B) Intensity of f-actin staining in the p-region was 
significantly reduced (from 79.4 ± 4.8 to 65.1 ± 4.4) by treatment with 30 nM Cyto B (p ≤ 0.05 
as compared to Control).  Treatment with 500 nM Cyto B reduced the intensity of f-actin 
staining within the p-region to an even greater extent (to 37.7 ± 3.0; p ≤ 0.001 as compared to 
Control). (C) Actin bundle intensity was not affected by treatment with 30 nM Cyto B (p = 0.23 
as compared to Control).  However, treatment with 500 nM Cyto B significantly reduced actin 
bundle intensity from 110.0 ± 4.4 to 58.2 ± 3.9 (p ≤ 0.001 as compared to Control). 
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resulted in filopodial elongation by increasing g-actin addition to the barbed end and/or by 
inhibiting f-actin’s retrograde flow. Because the magnitude of filopodial elongation seen after 
treatment with either wortmannin (to block PI-3K) or blebbistatin (to block retrograde flow) was 
similar, (approximately 25-30% for both at 10 min) (Fig. 2.9B and C) it was possible that PI-3K 
inhibition blocked retrograde flow. To test this hypothesis, wortmannin was applied in the 
presence of blebbistatin. Interestingly, the effect on filopodial elongation was as large or even 
larger than the numerical sum of the effects seen with either wortmannin or blebbistatin 
treatment alone, reaching a 63 ± 8% increase in filopodial length after 10 min (p ≤ 0.01 and p ≤ 
0.05 compared to wortmannin and blebbistin alone) (Fig. 2.9B and C). This observation was 
consistent with a mechanism by which wortmannin, increased filopodial length by increasing 
actin polymerization at the barbed end. To investigate this likely mechanism further, we 
inhibited PI-3K in the presence of Cyto B with the assumption that if PI-3K inhibition increased 
actin polymerization onto the barbed end, we should be able to block the effect on filopodial 
elongation in the presence of Cyto B. Whereas wortmannin caused an increase in filopodial 
length of 25.8 ± 6.4% after 10 min, this effect was inhibited significantly after a 10 minutes 
preincubation with 30 nM Cyto B (p ≤ 0.01) (Fig. 2.9B and C). This result suggested that actin 
polymerization is the major factor by which PI-3K inhibition causes filopodial elongation. 
Moreover the observation that there was no significant difference in the effects of treatment with 
Cyto B plus wortmannin and with Cyto B by itself further supported the hypothesis that the PI-
3K inhibitor, wortmannin, increased filopodial length by increasing actin polymerization at the 
barbed end. 
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Discussion 
Phosphatidylinositol-3-kinase (PI-3K) is central to many signaling pathways and has been shown 
to function in cellular events such as cell survival, mitogenesis, differentiation and motility 
(Duronio et al., 1998; Krasilnikov, 2000; Cantrell, 2001; Rodgers and Theibert, 2002). PI-3K can 
be activated by receptor tyrosine kinases, non-receptor tyrosine kinases, and G-protein coupled 
receptors (Stephens et al., 1994; Stoyanov et al., 1995; Lopez-Ilasaca et al., 1997; Duronio et al., 
1998; Vanhaesebroeck and Waterfield, 1999; Cantrell, 2001) but the mechanism by which PI-3K 
affects neurite outgrowth is not well understood. Here we set out to investigate whether the effect 
of PI-3K on neurite outgrowth might be explained by its action on the actin cytoskeleton in 
neuronal growth cones.  
 
PI-3K signaling events regulate filopodial dynamics and neurite outgrowth 
Inhibition of PI-3K with wortmannin induced a rapid increase in filopodial length. 
Filopodial elongation was observed at micromolar concentrations of wortmannin at which this 
drug is not solely specific for PI-3K but can also affect PI-4K (Rodgers and Theibert, 2002). We 
do not think that this activity interfered with PI-3K inhibition, because the same increase in 
filopodial length was observed after treatment with a second, more specific PI-3K inhibitor, LY 
294002. The fact that two different specific inhibitors induced the same effect on filopodial 
length strongly suggests that PI-3K activity regulates filopodial dynamics. The study of the 
dynamic parameters of filopodia, by tracking individual filopodia at 30 second intervals, showed 
that the overall filopodial elongation induced by PI-3K inhibition was produced by an increase in 
the time individual filopodia spent extending and by an increase in the extension rate of 
individual filopodia.  
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In addition to its effect on filopodia, treatment with the specific PI-3K inhibitor, LY 294002, also 
caused a significant decrease in the rate of neurite outgrowth in the first and second hour of PI-
3K inhibition (Fig. 2.2). This decrease in outgrowth likely resulted from a mechanism other than 
affecting filopodial motility, since filopodial dynamic parameters were virtually unchanged 
before and two hours after treatment with the PI-3K inhibitor. Instead, it is reasonable to assume 
that the PI-3K inhibitor acted on microtubules, because neuronal growth rates are dependent on 
microtubule dynamics (Bamburg et al., 1986; Gordon-Weeks, 1991) and recent evidence 
suggests that PI-3K activity can regulate microtubules (Zhou et al., 2004; Zhou and Snider, 
2005). 
Our results on the role of PI-3K signaling on neurite outgrowth are in agreement with studies 
on other cell types. Pharmacological inhibition of PI-3K reduces neurite outgrowth in mouse 
DRG and hippocampal neurons (Wu et al., 1998; Edstrom and Ekstrom, 2003), as well as in 
PC12 cells (Jackson et al., 1996). On the other hand, PI-3K activation by NGF has been shown 
to increase axon outgrowth in DRG neurons by inactivation of GSK-3ß and the involvement of 
the microtubule plus end binding protein APC (Zhou et al., 2004), although NGF stimulation has 
also been reported to signal via the MAPK pathway (Goold and Gordon-Weeks, 2005). Taken 
together, inhibition of PI-3K elicits filopodial elongation and a concomitant decrease in neurite 
advance, a phenomenon we have previously described to occur in response to treatment with 
nitric oxide (Trimm and Rehder, 2004) and termed ‘slow down and search’ behavior. 
 
ROCK, Akt, and MEK regulate filopodial dynamics and neurite outgrowth  
PI-3K can be activated by receptor- and non-receptor tyrosine kinases, as well as by G-
protein coupled receptors (Stephens et al., 1994; Stoyanov et al., 1995; Lopez-Ilasaca et al., 
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1997; Duronio et al., 1998; Vanhaesebroeck and Waterfield, 1999; Cantrell, 2001). PI-3K, in 
turn, has two modes of action. It functions as a lipid kinase by phosphorylating the 3’-OH 
position on the inositol ring of several phosphoinositides, thereby producing inositol lipid 
products, which are important mediators of intracellular signaling (Duronio et al., 1998; 
Vanhaesebroeck and Waterfield, 1999; Cantrell, 2001). This signaling pathway leads to the 
stimulation of guanine nucleotide exchange factors for Rho-GTPases, as well as to the activation 
of the PH-domain containing kinase, PDK-1, which in turn activates Akt (Alessi et al., 1997; 
Downward, 1998; Meier and Hemmings, 1999; Vanhaesebroeck and Alessi, 2000) (Fig. 2.3). 
Secondly, PI-3K functions as a protein kinase resulting in the activation of the Ras/Raf/Erk 
pathway (Bondeva et al., 1998; Vanhaesebroeck and Waterfield, 1999; Krasilnikov, 2000).  
Given the complexity of PI-3K signaling, we here concentrated on three key kinases 
downstream of PI-3K activity, namely ROCK, Akt, and MEK. Inhibition of any of these kinases 
led to an overall increase in filopodial length, which resulted from an increase in both the 
extension rate and the time filopodia spent extending. This finding was somewhat unexpected, 
since it suggested that all three kinases were able to affect filopodial length and could play a role 
in regulating growth cone dynamics during neuronal pathfinding (Fig. 2.3). The finding that the 
simultaneous inhibition of Akt, ROCK and MEK mimicked the inhibition of PI-3K itself, and 
induced a stronger filopodial elongation than when each kinase was inhibited individually, 
suggested that the three pathways might interact to regulate actin dynamics. Interestingly, 
simultaneous inhibition of the two kinases in the lipid kinase branch of PI-3K activity, namely 
ROCK and Akt, had no additive effect, indicating that their actions may have a common 
downstream element. Inhibition of one member each of the lipid kinase (ROCK) and protein 
kinase pathways (MEK), however, resulted in an additive effect, suggesting that ROCK and 
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MEK might affect filopodial length by different pathways that converge on elements regulating 
actin dynamics (Fig. 2.3). 
Akt is crucial to cell survival and the inhibition of Akt has been demonstrated to cause 
cell death (Dudek et al., 1997). Since cell death is a process occurring on a much longer time 
scale than the effects on filopodial length, we were less concerned that the filopodial response 
could be a consequence of apoptosis in response to Akt inhibition. Rather, the time scale of 
minutes indicated a direct signaling pathway involving the cytoskeleton locally.  
In addition to the effects on filopodial behavior, we found that inhibition of two of the 
downstream targets of the lipid kinase pathway, Akt or ROCK, resulted in a decrease in neurite 
outgrowth in the second hour following drug addition (Fig. 2.5A and B). This late onset of an 
effect on neurite outgrowth, compared to an effect on filopodial elongation observed within 
minutes, suggested that filopodial elongation could occur without a concomitant decrease in 
neurite outgrowth. As such, the slow-down and search behavior seen in this study can be divided 
into two behaviors: “slow-down” and “search” (Fig. 2.11). As observed with both ROCK and 
Akt inhibition, it is possible for a growth cone to elongate its filopodia over a short time course 
(the “search” behavior) while maintaining a constant outgrowth speed. Yet, at other times these 
behaviors can be coupled into the “slow-down and search” behavior that is seen with PI-3K 
inhibition (Fig. 2.1B, Fig. 2.2) in the first hour of drug addition. Given that the treatments in this 
study were long-term and may not reflect shorter and probably more physiologically relevant 
episodes of kinase activation/inhibition, one could envision scenarios in which changes in 
filopodial length and neurite outgrowth rates could either be regulated independently or in 
conjunction, depending on the signaling cues received by the pathfinding growth cone. RhoA, an 
activator of ROCK, has been shown to have opposite effects on neurite outgrowth depending 
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on the cell type and the stage of outgrowth studied (Kranenburg et al., 1997; Threadgill et al., 
1997; Kuhn et al., 1999; Sebok et al., 1999). In agreement with ROCK promoting neurite 
outgrowth, inactivation of RhoA has been shown to slow the rate of neurite outgrowth in NGF-
primed differentiating PC12 cells (Sebok et al., 1999).  
While we found that inhibition of Akt resulted in a slowing of neurite outgrowth, other 
recent studies reported the opposite effect, namely that expression of a dominant inhibitory form 
of Akt increased NGF induced neurite outgrowth in PC12 cells (Bang et al., 2001; Piiper et al., 
2002). This difference in results may be explained by the fact that while we investigated neurite 
outgrowth on already extended neurites, the other studies focused on neurite initiation. It is, thus, 
possible that Akt may affect neurite initiation and neurite maintenance differently, as has been 
reported for RhoA (Sebok et al., 1999).   
 
PI-3K signaling events alter filopodial length by regulating actin dynamics 
Changes in filopodial length mainly result from a change in the balance of actin 
polymerization and depolymerization at the ends of bundled f-actin polymers in filopodia, and by 
altering the rate of retrograde f-actin flow (Lin et al., 1996; Mallavarapu and Mitchison, 1999). 
In an attempt to determine which of these mechanisms were involved in producing filopodial 
elongation after PI-3K inhibition, we used several drugs known to interfere with actin 
polymerization (cytochalasin B) and myosin II activity (blebbistatin), the latter being implicated 
in driving the retrograde actin flow (Brown and Bridgman, 2003). Our finding that the filopodial 
elongation induced by PI-3K inhibition was blocked after pretreatment with cytochalasin B 
demonstrated that PI-3K activity controls actin dynamics. More specifically, the results are in 
agreement with the hypothesis that inhibition of PI-3K increases actin polymerization at the 
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barbed end, although possible effects of PI-3K on actin depolymerization at the pointed end 
cannot be ruled out. Alternatively, elongation could come about by a decrease or stoppage of 
retrograde flow (Jay, 2000) and no change at the barbed end. This possibility was made less 
likely by the finding that inhibition of the myosin II ATPase activity with blebbistatin, which 
would block retrograde flow and result in an increase in filopodial length, showed an additive 
affect when combined with PI-3K inhibition, resulting in an increase in filopodial length of 
greater than 60%. Taken together our results suggest that while filopodial elongation can be 
achieved independently by inhibiting myosin II activity or by increasing the addition of g-actin 
to the barbed end, the filopodial elongation in response to PI-3K inhibition can be explained best 
by an increase in actin polymerization. This result is supported further by a report on retinal 
ganglion neurons in which filopodial elongation elicited by inhibition of either ROCK or myosin 
II were additive, making it unlikely that ROCK acted through myosin II (Gehler et al., 2004).  
Actin associated proteins, such as profilin and cofilin, control actin dynamics (Pollard and 
Cooper, 1986; Stossel, 1989). Profilin inhibits actin assembly at the barbed end by binding and 
sequestering actin monomers (Stossel, 1989). Phosphoinositides prevent the profilin-actin 
monomer association by binding to profilin, with Ptdins(3,4)P2 (PIP2) having a higher affinity 
than Ptdins(3,4,5)P3 (PIP3) (Goldschmidt-Clermont et al., 1991; Lu et al., 1996). Moreover, 
profilin affinity for actin monomers has been shown to be increased by PI-3K dependent 
phosphorylation (Sathish et al., 2004). Therefore filopodial elongation induced by PI-3K 
inhibition could be due to an increase in profilin-PIP2 binding and to a decrease in 
phosphorylated profilin. Actin polymerization could also be increased by preventing barbed end 
capping through profilin binding proteins of the Ena/VASP family (Bear et al., 2002; Krause et 
al., 2003) which are localized to the tips of filopodia (Lanier et al., 1999). 
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Filopodial elongation observed after ROCK inhibition is consistent with two recent studies 
on chick retinal neurons, in which BDNF binding to p75 neurotrophin receptors induces 
filopodial elongation by inactivating the ROCK effector, RhoA in retinal ganglion neurons 
(Gehler et al., 2004; Gehler et al., 2004). Filopodial elongation also resulted when ROCK was 
inhibited directly.  Moreover, the effect of BDNF was shown to be mediated through an 
activation of the complex cofilin - actin-depolymerizing factor (referred to as ADF/cofilin) and 
not though an action of ROCK on myosin II activity.  ADF/cofilin is an important regulator of 
actin dynamics (Gungabissoon and Bamburg, 2003), as it disassembles actin monomers from the 
pointed end and severs actin filaments, thereby producing more barbed ends in the process (Chen 
et al., 2000). Whether activation of ADF/cofilin is involved in filopodial elongation in response 
to PI-3K inhibition in B5 neurons is presently unclear.  
 
A calcium-independent form of slow down and search behavior 
In an earlier study that investigated the effect of nitric oxide (NO) on growth cone behavior, 
we described the increase in filopodial length coupled with a slow-down in neurite advance as 
‘slow-down and search’ behavior (Trimm and Rehder, 2004). Interestingly, NO acted via soluble 
guanylyl cyclase and led to an increase in the free intracellular calcium concentration [Ca2+]i. In 
the present study, we performed Ca2+-imaging experiments and found no measurable changes in 
[Ca2+]i with any of the drug treatments, suggesting that a ‘slow-down and search’ behavior can 
also be elicited in a Ca2+-independent fashion. Thus, a Ca2+ dependent (NO) and a Ca2+ 
independent (PI-3K) pathway appear to converge onto cytoskeletal regulators to similarly affect 
filopodial dynamics and neurite outgrowth. Actin binding proteins such as ADF/cofilin and 
annexin might serve as such convergence points, as they have been shown to be regulated by 
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Ca2+, phophatidylinositide binding and phosphorylation/dephosphorylation events (Bamburg, 
1999; Hayes et al., 2004).  
 
Filopodial length and number can be regulated independently 
Interestingly, inhibition of PI-3K and kinases downstream had no significant effects on 
another morphological growth cone parameter, filopodial number. In previous studies, we had 
described that filopodial elongation was often coupled to a decrease in filopodial number (Van 
Wagenen and Rehder, 1999; Cheng et al., 2000). The present study provides strong evidence that 
the parameters length and number can be regulated independently from each other. This may be 
of significance to a navigating growth cone, which would be able to increase its action radius by 
elongating its filopodia without losing spatial resolution through a decrease in the number of 
sensors. We observed a similar uncoupling in filopodia length and number after local uncaging 
of Ca2+ in growth cones (Cheng et al., 2002), which resulted in a transient elongation of filopodia 
for approximate 30 min. in response to an increase in intracellular Ca2+  lasting several seconds. 
 
CONCLUSIONS 
Taken together, our results demonstrate that signaling events leading to the inhibition of PI-3K 
resulted in an increase in filopodial length and a decrease in neurite outgrowth, and as such could act 
as a signal for a slow-down and search behavior (Fig. 2.11). Inhibition of key kinases located 
downstream of PI-3K activity also resulted in filopodial elongation (ROCK, Akt, and MEK) and in a 
decrease in neurite advance (ROCK and Akt), consistent with the notion that PI-3K might act 
through these kinases to affect growth cone motility. In extension, other signaling pathways  
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Figure 2.11: Model of regulation of neurite outgrowth and filopodial motility by PI-3K. 
(A) Baseline PI-3K activity leads to downstream signaling events that result in growth cones 
advancing with ‘baseline’ speed and having filopodia of certain lengths. (B) When PI-3K or key 
kinases in the proposed pathway downstream of PI-3K are inhibited or otherwise reduced in their 
activity, growth cones undergo a “slow-down and search” behavior, characterized by filopodial 
elongation and a concomitant decrease in the rate of neurite advance. Note that depending upon the 
duration or intensity with which a pathway is inhibited, the growth cone may respond with either the 
combined slow down and search behavior or with filopodial elongation (“search”) alone. 
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converging on these kinases are expected to have predictable effects on neurite outgrowth and 
filopodial behavior.  Filopodial elongation in response to PI-3K inhibition was shown to result  
largely from an increase in actin polymerization, and not from an inhibition of the retrograde flow. 
The detailed pathways that link the activity of these kinases to changes in the growth cone 
cytoskeleton will have to be investigated in future studies. 
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Chapter 3 : Nitric Oxide Release from a Single Cell Affects Filopodial Motility on Growth 
Cones of Neighboring Neurons 
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Abstract 
Nitric oxide (NO), a gaseous messenger, has been reported to be involved in a variety of 
functions in the nervous system, ranging from neuronal pathfinding to learning and memory. We 
have shown previously that the application of NO via NO donors to growth cones of identified 
Helisoma buccal neurons B5 in vitro induces an increase in filopodial length, a decrease in 
filopodial number, and a slowing in neurite advance. It is unclear, however, whether NO released 
from a physiological source would affect growth cone dynamics. Here we used cell bodies of 
identified neurons known to express the NO synthesizing enzyme nitric oxide synthase (NOS) as 
a source of constitutive NO production and tested their effect on growth cones of other cells in a 
sender-receiver paradigm. We showed that B5 cell bodies induced a rapid increase in filopodial 
length in NO-responsive growth cones, and that this effect was blocked by the NOS inhibitor 7-
NI, suggesting that the effect was mediated by NO. Inhibition of soluble guanylyl cyclase (sGC) 
with ODQ blocked filopodial elongation induced by B5 somata, confirming that NO acted via 
sGC. We also demonstrate that the effect of NO was reversible and that a cell releasing NO can 
affect growth cones over a distance of at least 100 µm. Our results suggest that NO released from 
a physiological source can affect the motility of nearby growth cones and thus should be 
considered a signaling molecule with the potential to affect the outcome of neuronal pathfinding 
in vivo. 
 
Introduction 
Nitric oxide (NO), a gaseous messenger, has been described to play an important role 
during neuronal development, such as in the formation of retinal projections in vivo (Williams et 
al., 1994; Cramer et al., 1996; Gibbs and Truman, 1998; Cramer and Sur, 1999; Ernst et al., 
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1999; Wildemann and Bicker, 1999; Wu et al., 2000), but also in neuronal differentiation and 
neurite outgrowth in general (Hess et al., 1993; Peunova and Enikolopov, 1995; Hindley et al., 
1997; Poluha et al., 1997; Nakaya et al., 2000; Rialas et al., 2000; Gallo et al., 2002). During the 
development of the grasshopper embryo, NO, potentially released from epithelial cells facing the 
basal lamina of the developing antenna, has been shown to regulate axonal pathfinding of 
antennal pioneer neurons (Seidel and Bicker, 2000; Bicker, 2007). We have shown previously 
that NO donors applied to identified Helisoma B5 neurons grown in vitro induce an increase in 
filopodial length and a concomitant decrease in neurite outgrowth (Van Wagenen and Rehder, 
1999; Trimm and Rehder, 2004; Welshhans and Rehder, 2005), suggesting that some of the 
developmental effects of NO described in the literature might result from NO acting on neuronal 
growth cones. A follow up study, in which NO donors were applied focally to B5 growth cones, 
indeed confirmed that NO regulates filopodial motility locally at the growth cone and that the 
NO signaling pathway included soluble guanylyl cyclase (sGC), protein kinase G (PKG), cyclic 
adenosine diphosphate ribose (cADPR) and intracellular calcium release from ryanodine 
sensitive stores (Welshhans and Rehder, 2005; Welshhans and Rehder, in press). While the 
application of NO donors has proven to be a practical approach to test effects of NO in numerous 
preparations, it is not known whether NO released physiologically from other cells would affect 
growth cone motility as well. It has been shown both in vivo and in vitro that cellular release of 
NO can have measurable effects on neighboring cells, such as acting as a modulator of neuronal 
excitability (Elphick et al., 1995; Park et al., 1998). 
  The ultimate determination whether cellular release of NO can affect growth cone motility in 
another cell by acting in a paracrine fashion has not yet been made. In this study we used cell bodies 
of identified neurons known to express the NO synthesizing enzyme nitric oxide synthase (NOS) as 
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sources of constitutive NO production and paired them with growth cones to be tested for their 
response to NO. To facilitate the testing, neuronal somata adhering to a poly-L-lysine coated 
microelectrode were maneuvered into the vicinity of growth cones (distances ranging from 20-150 
µm) and filopodial dynamics were recorded before and at defined times after stimulation. We here, 
to our knowledge for the first time, demonstrate that neuronally released NO is effective in altering 
filopodial motility on growth cones of neighboring neurons. This finding not only suggests a role for 
NO in neuronal pathfinding, but also provides a straightforward physiological paradigm to study the 
effects of NO on cell motility in general. 
 
Methods and Materials 
Neuronal culture and image acquisition 
Identified B5 and B19 neurons were dissected from Helisoma trivolvis buccal ganglia and plated 
for neuronal culture. Neurons to be investigated for the effect of NO on growth cone morphology 
(referred to as “Receivers”) were plated on poly-L-lysine (hydrobromide, MW 70,000-150,000, 
0.25mg/ml, Sigma, St. Louis, MO) coated glass coverslips glued to the bottoms of a 35 mm cell 
culture dishes (Falcon 1008). These cells were grown overnight at room temperature and used 
24-48 hours after plating (Fig. 3.1A). Cells used as sources of NO (referred to as “Senders”) 
were obtained by placing freshly harvested cell bodies into hemolymph-coated glass dishes 
according to Spencer et al. (2000) to prevent them from adhering to the substrate. These cells 
were kept at room temperature and used within 24 hours after plating (Fig. 3.1A). “Receiver” 
cells were plated into conditioned medium (CM), prepared by incubating snail brains in modified 
Leibowitz L-15 medium (Gibco, Grand Island, NY) for 3-4 days. L-15 medium was prepared to 
contain final concentration of: 40 mM NaCl, 1.7 mM KCl, 1.5 mM MgCl2, 4.1 mM CaCl2, 10  
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Figure 3.1: Schematic of the experimental design.  
(A) Sender dishes (coated with hemolymph) contain neuronal cell bodies to be used as NO 
“senders”, whereas receiver dishes are coated with poly-L-lysine and contain conditioned medium to 
support neurite outgrowth from neurons to be tested in the sender/receiver paradigm. Senders are 
transferred to the receiver dish with a fire-polished micropipette. (B) Sender neurons are attached to 
a poly-L-lysine coated glass micropipette which is subsequently positioned by a motorized 
micromanipulator to hold the sender at variable distances, ranging from 20-150 µm from a 
“receiver” growth cone. 
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mM HEPES, 50 µg/ml gentamycin, 0.15 mg/ml glutamate in distilled water (pH=7.3) (Cohan et 
al., 2003). A fire-polished micropipette, connected hydraulically via plastic tubing to a 
micrometer syringe (Gilmont Instruments), was used to transfer an individual “Sender” cell body 
into the culture dish containing the neuron to be tested. The “sender” cell body was subsequently 
maneuvered into the proximity (20-150 µm) of the “receiver” growth cone by using a poly-L-
lysine-coated microelectrode attached to a micromanipulator (Spencer et al., 2000) (Fig. 3.1B). 
Growth cones were viewed under a 100x oil immersion objective on a Sedival (aus Jena, 
Germany) microscope. A regular CCD camera (Model: C-72, MIT Dage, Michigan City, IN)  
was used to capture images, which were digitized on a frame grabber (Scion LG-3, Scanalytics, 
Fairfax, VA) and analyzed with “Scion Image” software (Scion Corporation; Frederick, 
Maryland) on a Hewlett-Packard Pavilion (Hewlett-Packard Company, Palo Alto, CA).  
Pharmacological agents 
7-NI (7-Nitroindazole, nNOS inhibitor) and ODQ (1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one, 
soluble guanylyl cyclase inhibitor) were dissolved in dimethylsulfoxide (DMSO, Sigma) to obtain 
stock concentrations of 10 and 20 mM respectively. All drugs were purchased from Calbiochem 
(San Diego, CA).  
Design and analysis of growth cone dynamics 
Observation of filopodial length and number were performed at defined times before and 
after moving a “sender” cell body into the vicinity of the growth cone to be tested. Other growth 
cones on the same cell, but located at considerable distances from the growth cone to be tested, 
were used as controls (not stimulated by the sender) and labeled as “Non-receiver growth cone”. 
In experiments involving 20 min of preincubation with a pharmacological agent, drugs were 
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premixed in 2 mL of L-15 medium to obtain final concentrations, and introduced to the dish by 
complete medium exchange. Growth cone dynamics were analyzed during the preincubation 
period to determine whether any of the drugs would have an effect by itself. Images were 
captured before (-5 and 0 min) and at defined times (2, 5, 10, 15, 20, and 30 minutes) after 
maneuvering the sender into the vicinity of the growth cone.  
Digitized images of growth cones were analyzed by measuring the length of all 
individual filopodia from their tip to the edge of the central domain, preventing potential 
incorrect measurement influenced by lamellipodial dynamics. Filopodial length was measured 
for each filopodium on a growth cone from phase contrast images using the software package 
“Scion Image” and is expressed as mean filopodial length. To compensate for the variability 
observed in growth cone size and filopodial length between different growth cones, these values 
were expressed as a percentage change normalized to the time point t = 0 just prior to any 
manipulation.  
 
Statistical analysis 
 Analysis of variance (repeated measures ANOVA with time as repeated measures when 
appropriate), and t-test for independent samples with SuperANOVA (Abacus Concepts, Berkeley, 
CA) were performed to determine statistical significance between conditions. Fisher’s protected least 
significant difference (PLSD) test was used as post-hoc analysis of preplanned comparisons. 
Significant differences are indicated as: *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. 
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Results 
Growth cone dynamics are affected by a B5 sender/receiver paradigm  
To investigate if the physiological release of NO from a neuron could act as a messenger and affect 
nearby growth cones, we made use of the fact that B5 neurons express NOS (Van Wagenen and 
Rehder, 2001), produce NO (Ivanova and Rehder, unpublished results), and can therefore be used as 
a physiological source of NO. Other cells, such as the B19 neuron, were previously demonstrated to 
not contain significant NOS immunoreactivity and therefore have been used successfully as negative 
controls (Van Wagenen and Rehder, 2001). To make the stimulation paradigm as flexible as 
possible, we used a poly-L-lysine coated micropipette, which adheres well to any cell body and thus 
provides a handle by which a cell body can be moved easily within the dish (Spencer et al., 2000). 
Using this approach, cell bodies can be positioned and held at variable distances from growth cones 
of other cells growing in the culture dish. The “sender” is subsequently maneuvered into position 
close to a growth cone to be tested (referred to as the “receiver”). Stimulation of a B5 receiver 
growth cone by a B5 sender positioned at a distance of 20-30 µm resulted in a significant and rapid 
elongation of filopodia when compared to the control condition, in which a poly-L-lysine coated 
micropipette was positioned at the same distance alone (p ≤ 0.001) (Fig. 3.2A and B). The 
elongation started as early as 2 minutes after the sender was moved into place and reached a plateau 
of 24.7 ± 2.5% after 10 minutes. Interestingly, the average number of filopodia on a given growth 
cone was not affected by the presence of the sender (p = 0.82) (Fig. 3.2C). Importantly, the effect of 
the sender was limited to the stimulated growth cone, as stimulation with a B5 sender for 15 minutes 
induced a significant increase in filopodial length on B5 receiver growth cones compared to other 
growth cones on the same cell that were located further away from the sender (p ≤ 0.001) (Fig. 
3.2D). These results, obtained with the sender/receiver paradigm, suggested that B5 neurons 
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Figure 3.2: Stimulation of B5 receiver growth cones by B5 senders results in an increase in 
filopodial length.  
(A) Phase contrast images of a representative B5 receiver growth cone 5 min before (pre) and 10 
min after stimulation by a B5 sender. Note strong filopodial elongation elicited by a B5 soma held 
approximately 30 µm ahead of the growth cone and located just outside of the image. Scale bar, 10 
µm. (B) B5 senders held at a distance of 20-30 µm from the growth cone to be tested caused a 
significant increase in filopodial length on B5 receivers as early as 2 min after placement of the 
sender and reached a plateau after 10 min when compared to pipette stimulation alone (p ≤ 0.001). 
Filopodial length was not affected by the pipette alone. Cell bodies of B19 neurons used as senders 
had no effect on filopodial length (p = 0.06). (C) B5 and B19 senders did not cause changes in 
filopodial number compared with the pipette treatment alone (p = 0.82 and p = 0.83 respectively). 
The pipette alone did not change filopodial number. (D) A 15 min stimulation with a B5 sender 
induced a significant increase in filopodial length on B5 receiver growth cones compared to growth 
cones on the same cell located farther away from the sender (p ≤ 0.001). 
For all experiments the number of growth cones studied per condition is given as ‘n’.  
Statistical significance between conditions is symbolized by asterisks as follows: *p ≤ 0.05, **p ≤ 
0.01, ***p ≤ 0.001. 
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release a diffusible factor(s) that can affect filopodial dynamics on B5 growth cones nearby. 
To confirm that the effect of the B5 sender was owing to the release of NO and not some 
other diffusible factor released by neurons, we next tested the effect of another identified neuron, 
B19, which does not express nNOS (Van Wagenen and Rehder, 2001). When B19 cell bodies were 
used as the sender and positioned approximately 20 µm from B5 growth cones, filopodial length and 
number were not significantly affected (p = 0.06 and p = 0.83 respectively) when compared to the 
micropipette alone group, but filopodial length differed significantly from the condition in which a 
B5 neuron was used as the sender (p ≤ 0.01) (Fig. 3.2B and C). Not surprisingly, the B19 sender also 
had no significant effect on filopodial number (p = 0.99, as compared to B5 senders) (Fig. 3.2C). 
To test independently whether the effects of a B5 sender were mediated by NO, B5 
sender/receiver pairs were preincubated with the specific nNOS inhibitor 7-NI (10 µM) for 20 
minutes before moving the B5 sender into the proximity of the receiver growth cone. Treatment with 
7-NI blocked the filopodial elongation normally induced by B5 senders (p ≤ 0.001, Fig. 3.3A), and 
had no effect on filopodial number (p = 0.18) (Fig. 3.3A and B). Preincubation with 7-NI by itself 
had no effect on filopodial dynamics (Fig. 3.3A and B). Taken together, these results support the 
hypothesis that B5 senders affect growth cone morphology of neurons in their vicinity by releasing 
NO. 
 
sGC mediates the response of growth cones to NO released by a physiological source 
 The NO signaling pathway has been shown to act mainly through activation of 
soluble guanylyl cyclase (sGC) (Arnold et al., 1977; Ahern et al., 2002), and direct S-nitrosylation of 
proteins (Jaffrey et al., 2001). Because we had shown previously that NO donors induce changes  
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Figure 3.3: Inhibition of nNOS prevents the B5 sender-induced increase in filopodial 
length.  
(A) Pretreatment with the nNOS inhibitor 7-Nitroindazole (7-NI) (10 µM) for 20 min abolished the 
increase in filopodial length induced by B5 senders (p ≤ 0.001 compared with B5 senders alone). 7-
NI itself had no effect on filopodial length. (B) Pretreatment with 10 µM 7-NI followed by 
stimulation with B5 senders did not change filopodial number (p = 0.18 compared with B5 senders 
alone). Filopodial number was not affected by 7-NI itself. Note that the data for the B5 sender from 
Fig. 3.1B and C have been added to facilitate comparison. 
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in growth cone morphology of B5 neurons through activation of sGC (Van Wagenen and 
Rehder, 1999), it was important to confirm that NO released from a physiological source in the 
sender/receiver paradigm would act through the same signaling pathway. To this end, B5 
sender/receiver pairs were preincubated with the sGC inhibitor ODQ (20 µM) for 20 minutes 
before moving the sender into the proximity of the receiver growth cone. Treatment with ODQ 
blocked changes in filopodial length normally induced by B5 senders (p ≤ 0.001) (Fig. 3.4A). 
Again, filopodial number was not affected by this experiment (p = 0.17) (Fig. 3.4B). The 
incubation with ODQ alone did not affect growth cone morphology (Fig. 3.4A and B). These 
results are consistent with our previous findings and suggest that the NO released from a 
physiological source acts via its canonical target, sGC, to regulate filopodial length.  
 
The effect of NO released from a physiological source is reversible and distance- dependent 
 Previous studies from our laboratory showed that application of the NO donor SIN-1 to an 
entire cell culture dish (global stimulation) induced a rapid increase in filopodial length which 
showed a transient peak and a subsequent sustained plateau (Van Wagenen and Rehder, 1999; Van 
Wagenen and Rehder, 2001). By contrast, short-term stimulation with the NO donor NOC-7 applied 
locally to a growth cone via a micropipette for about 40 ms caused only transient filopodial 
elongation (Welshhans and Rehder, 2005), suggesting that the NO effect is dependent on the 
duration of the stimulation with NO. This hypothesis was supported further by the findings in this 
paper, in which we demonstrate that filopodia remained elongated in the presence of the B5 sender  
(Fig. 3.2B). Therefore, we next investigated whether the effect of NO on filopodial length was 
reversible. To address that question, B5 senders were maneuvered into the proximity of B5 receivers 
(20-30 µm) for 15 minutes, then the senders were subsequently moved away and filopodial  
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Figure 3.4: Inhibition of sGC abolishes the B5 sender-induced increase in filopodial length.  
(A) Pretreatment with the sGC inhibitor 1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) 
(20 µM) for 20 min prevented the increase in filopodial length induced by B5 senders (p ≤ 0.001 
compared with B5 senders alone). ODQ itself had no effect on filopodial length. (B) 
Pretreatment with 20 µM ODQ followed by stimulation with B5 senders did not result in a 
change in filopodial number (p = 0.17 compared with B5 senders alone). Filopodial number was 
not affected by ODQ itself. Note that the data for the B5 sender from Fig. 3.1B and C has been 
added to facilitate comparison. 
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length re-assessed one hour later. Whereas filopodial length increased by 28.9 ± 4.7% after 15 
minutes of pairing with a B5 sender, subsequent removal of the sender resulted in a significant 
decrease in filopodial length toward baseline, reaching 12.5 ± 3.5% above pretreatment levels after 1 
hour (p ≤ 0.01) (Fig. 3.5A). It is interesting to note that filopodial length did not return to baseline 
even after 2 hours of sender removal (data not shown), suggesting that the exposure to NO had 
resulted in a long term change in the receiver growth cone. To test if a growth cone would be 
responsive to a second exposure of NO, a B5 sender was brought in again after one hour and 
positioned 20 µm away from a receiver growth cone. This second exposure to a sender induced 
another significant increase in filopodial length from the previously elevated plateau of 12.5 ± 3.5% 
to 34 ± 4.3% after 30 minutes (p ≤ 0.001) (Fig. 3.5A). It is interesting to note that there was no 
significant difference between the degree of filopodial elongation induced by the first and second 
presentation of the sender (p = 0.283). These results suggested that the effect of NO release from a 
physiological source, while being partially reversible, has a long lasting effect on the receiver. 
Nevertheless, growth cones were capable of responding with filopodial elongation to a second 
exposure to a B5 sender, suggesting that they had maintained their sensitivity to NO. 
Next we investigated the distance over which a sender could affect the morphology of a 
receiver growth cone. To this end, we systematically increased the distance between the sender and 
the receiver. There was no significant difference in the degree of filopodial elongation when a B5 
sender was placed at a distance of either 20-30 µm or 60 µm (p = 0.334) from a receiver growth cone 
(23.9 ± 2.4% and 26.3 ± 3.4% respectively after 15 minutes (Fig. 3.5B). When the B5 sender was 
located at a distance of 100 µm, filopodial elongation was significantly reduced, to 11.9 ± 2.1% (p ≤ 
0.05 and p ≤ 0.001 compared to 20-30 µm and the control (pipette) respectively) (Fig. 3.5B). When 
the distance between sender and receiver was increased further to 150 µm, the sender no longer had 
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Figure 3.5: A B5 sender can act over a distance of at least 100 µm and its effect on 
filopodial length is partially reversible.  
(A) Removal of B5 senders from B5 receiver growth cones for 60 min resulted in a significant 
reduction in filopodial length on growth cones stimulated previously by a sender for 15 min (p ≤ 
0.01). Growth cones remained responsive to NO after sender removal, because moving a sender 
back into the proximity of a receiver growth cone for 30 min (also see above) resulted in another 
significant increase in filopodial length (p ≤ 0.001). (B) Stimulation with B5 senders held to a 
distance of 60 µm induced the same degree of filopodial elongation as senders held at 20-30 µm 
(p = 0.334). Senders held at 100 µm induced filopodial elongation (p ≤ 0.001 compared with 
pipette), but the elongation was significantly less then the one induced by senders held at 20-30 
um (p ≤ 0.05). Senders held at 150 µm had no effect on filopodial length (p = 0.184). 
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a measurable effect on the receiver (p = 0.184). This series of experiments suggested that the 
effective distance over which NO can have a physiological effect on filopodial dynamics in this in 
vitro preparation is at least 100 µm. 
 
Discussion 
In the nervous system, nitric oxide has been shown to be involved in numerous processes, 
including development, synaptic plasticity, and cell death (Ernst et al., 1999; Lipton, 1999; 
Thippeswamy et al., 2001; Contestabile and Ciani, 2004; Regulski et al., 2004; Matarredona et 
al., 2005; Bicker, 2007; Hara and Snyder, 2007; McFarland et al., 2007). NO is produced 
enzymatically by nitric oxide synthase (NOS), which has 3 isoforms: neuronal (nNOS), inducible 
(iNOS) and endothelial (eNOS) (Garthwaite, 1991). NO is known to act by several mechanisms, 
including the activation of the enzyme soluble guanylyl cyclase (sGC) by the binding of NO to 
its heme moiety (Dierks and Burstyn, 1996), nitrosylation of cysteine residues in proteins to 
produce S-Nitrosothiols (Arnold et al., 1977; Stamler et al., 1992; Jaffrey et al., 2001; Ahern et 
al., 2002), and nitration of tyrosine residues (Ischiropoulos, 1998). In addition to its effect on 
protein regulation, NO can also act on DNA (Wink et al., 1991). 
During nervous system development and regeneration, neuronal pathfinding describes the 
process by which growth cones navigate to their targets, using diffusible and membrane bound 
cues encountered along the way. There are many guidance cues, such as netrins, semaphorins, 
ephrins and cell adhesion molecules, which are known to signal to the passing growth cone and 
potentially affect the speed and direction of growth cone advance (Tessier-Lavigne and 
Goodman, 1996; Dickson, 2002; Chilton, 2006), however the potential of the gaseous messenger 
NO to affect neuronal pathfinding and cell motility is only beginning to be explored. Early 
 100
studies used various NO donors to test the effect of NO on growth cone motility, neurite 
outgrowth and neurite initiation (Hindley et al., 1997; Van Wagenen and Rehder, 1999; Rialas et 
al., 2000; Gallo et al., 2002; Gendron et al., 2002; Trimm and Rehder, 2004; Zhang et al., 2005; 
Yamada et al., 2006). We have shown previously that global application of nitric oxide (NO) 
with NO donors can induce changes in both growth cone dynamics and neurite outgrowth in an 
identified neuron from the buccal ganglion of the mollusk Helisoma trivolvis. In the B5 neuron, 
NO induces an increase in filopodial length, a decrease in filopodial number and a decrease in 
neurite outgrowth (Van Wagenen and Rehder, 1999; Trimm and Rehder, 2004). Moreover, we 
have demonstrated that the increase in filopodial length is accomplished by an increase in both 
the velocity with which filopodia extend and the time they spend extending (Van Wagenen et al., 
1999). The reduction in the number of filopodia could be explained by a decrease in the rate with 
which new filopodia are inserted into the lamellipodial veil to make up for those filopodia being 
reabsorbed. In addition we have shown that NO induces the same changes in growth cone 
morphology when it is applied locally and only for a brief time to a single growth cone, a 
stimulus that potentially more closely mimics a physiological condition (Welshhans and Rehder, 
2005). 
Whereas the NO donors used in the experiments described above have different half 
times of release, which make them useful tools for testing effects of NO, a more physiologically 
relevant description of the effects of NO on the nervous system will have to include experiments 
in which the effects of cellular release of NO on cellular targets are studied. Studies in the 
grasshopper reported a role for NO in regulating neuronal migration in the enteric nervous 
system and axonal pathfinding of pioneer neurons in the antenna (Seidel and Bicker, 2000; 
Haase and Bicker, 2003; Bicker, 2007). While these studies clearly demonstrate that cell 
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migration is controlled by cells releasing NO along the path of migratory cells, a direct effect of 
cellular NO release on growth cone motility has yet to be demonstrated. 
Here we use a sender/receiver paradigm to study the effect of cellular NO release on 
growth cone motility. A cell that releases NO constitutively is used as the physiological NO 
source and functions as the sender which can be moved easily to any location within the dish. 
This approach is more convenient than plating two cells close to each other, in the hopes that 
their processes will grow towards each other. While the latter approach makes it difficult to 
control for the exact distance between sender and receiver, the movable sender paradigm 
increases the experimenter’s control over the experimental design.  
 
NO released from a physiological source affects growth cone dynamics via sGC 
Stimulation of B5 receiver growth cones by B5 sender cell bodies induced a strong and 
rapid increase in filopodial length (Fig. 3.2A and B). Interestingly this effect on filopodial 
dynamics was abolished by inhibition of NOS with the specific NOS inhibitor 7-NI (10 µM). 
Moreover, stimulation with B19 neurons (Fig. 3.2B), which were shown previously to contain 
little or no NOS immunoreactivity (Van Wagenen and Rehder 2001) had no effect on filopodia 
of B5 receivers, further supporting the hypothesis that filopodial elongation was NO-dependent. 
Other examples of an effect of neuronal NO release on neighboring cells exist, suggesting that 
release from one cell can affect the physiology of a neighboring cell. For example, electrical 
stimulation of B2 neurons in another mollusk, Lymnaea stagnalis, induces depolarization of 
B7nor neurons via signaling by NO in both the intact central nervous system and in cell culture 
(Park et al., 1998). In the hippocampus, evidence has been provided for NO to act as the elusive 
retrograde messenger in synaptic plasticity, namely long-term potentiation (Bohme et al., 1991; 
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O'Dell et al., 1991; Schuman and Madison, 1991; Bon and Garthwaite, 2001; Bon and 
Garthwaite, 2003; Hopper and Garthwaite, 2006). There is a convincing literature that 
neurotransmitters can affect neurite outgrowth (McCobb et al., 1988; Lipton and Kater, 1989; 
Spencer et al., 2000; van Kesteren and Spencer, 2003; Fricker et al., 2005; Homma et al., 2006; 
Ryan et al., 2007), and a sender/receiver paradigm similar to the one used in our study was 
employed with Lymnaea neurons to demonstrate that dopamine can affect growth cone motility. 
In this study, dopamine released from the right pedal dorsal 1 (RPeD1) neuron was shown to 
regulate growth cone behavior of target and non-target neurons differentially (Spencer et al., 
2000). Here we demonstrate that NO, released by a single cell, can have a strong effect on 
growth cones in its vicinity but not on growth cones located further away, clearly demonstrating 
that NO has the potential to affect neurite outgrowth locally. Our results also confirm earlier 
reports on the same cell type that demonstrated that NO brought about its effect on growth cone 
morphology and advance via activation of sGC (Van Wagenen and Rehder, 1999; Trimm and 
Rehder, 2004), as the effect of the sender on growth dynamics of the receiver was blocked in the 
presence of the sGC inhibitor ODQ (Fig. 3.4).  
 
The effect of cellular NO release on filopodial dynamics is reversible and dose dependent 
Whereas previous studies in vivo have demonstrated effects of NO on cell motility and 
neurite outgrowth (Gibbs and Truman, 1998; Chen et al., 2000; Seidel and Bicker, 2000; Haase 
and Bicker, 2003; Bicker, 2005), these experiments were mainly based on pharmacology to 
inhibit NO signaling and their conclusions were, therefore, somewhat indirect. Our results 
suggest that B5 neurons produce NO constitutively and that a growth cone entering the “plume” 
of NO created by such a sender cell would respond by elongating its filopodia. This is the first 
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report in which the effects of NO released from a single cell have been measured using growth 
cone motility as a sensitive bioassay. Our results clearly demonstrate that a single, unstimulated 
cell body can release enough NO to affect an advancing growth cone. Because NOS, in the case 
of the B5 neuron, is expressed throughout the entire neuron, we envision that even growth cones 
of B5 neurons can release NO, possibly affecting other cells in their vicinity. Clearly, the B5 
neuron may be unique in that it produces NO and also responds to it. As such, it could serve as a 
source of NO for its own purposes as well as supplying NO to the larger environment. We have 
shown previously that B5 neurons are responsive to the NO they produce constitutively, as 
neurite outgrowth slowed when either NOS or sGC was inhibited, suggesting that intrinsically 
produced NO plays a role in determining the speed of neurite advance (Trimm and Rehder, 
2004). It is reasonable to assume that other cells in the snail CNS will show a more conventional 
separation between NO producing and sGC expressing cells, making NO a paracrine modulator. 
Because the NOS enzyme is activated via Ca/calmodulin, it is likely that the amount of NO 
being produced and released by a B5 neuron will depend on the intracellular calcium 
concentration, and would thus be modulated by neuronal activity. Future studies will investigate 
the relationship of cellular electrical activity and NO release.  
Interestingly, the effect of NO release on filopodial length was reversible, as filopodia 
shortened again after the NO sender was removed, but the reversibility was incomplete, 
indicating that some long-term changes in the state of the growth cone had resulted from a 15 
minute exposure to NO. Additionally, it is expected that any effect of NO would be dose 
dependent. Modeling studies of NO release, taking into account the half life and diffusion of NO 
from a point source, suggest that NO might have physiological effects in a 200 µm diameter 
sphere (Lancaster, 1994; Wood and Garthwaite, 1994; Lancaster, 1997), but the action radius of 
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NO will clearly depend on the dynamics of NO production, its decay, and the general cellular 
environment.  Our result show clearly that the effect of NO varied inversely with the distance 
between the sender and the receiver growth cone. While maximal effect was seen between 20-60 
µm, NO still affected growth cones that were located 100 µm away, but failed to elicit an effect 
at 150 µm. These results fall nicely into the range of effective distances as reported above. It 
should be kept in mind, however, that our experiments were performed on single cells in vitro, 
and that the NO radius of action in the intact nervous system might well be different.  
NO released from tissues and cells within tissues has been detected by NO electrodes 
(Friedemann et al., 1996; Bedioui et al., 1997) and the use of fluorescent dyes, such as DAF-2A 
(Kojima et al., 1998), but a quantification of the amount of NO released from single cells is not 
trivial. Recently, Patel et al. (2006) reported that NO released from single neurons in the isolated 
CNS of Lymnaea stagnalis was detected by multiple film-coated electrode sensors. A cell-based 
indicator, called Picell, detected picomolar concentrations of NO released from single 
endothelial cells and hippocampal neurons in culture (Sato et al., 2006). These tools will be 
important in future investigations to directly measure the spatio-temporal NO release from B5 
senders.  
 
A role for NO in neuronal pathfinding and synaptogenesis 
Neuronal pathfinding takes place on the background of a rapidly changing nervous 
system, both molecularly and structurally. Well orchestrated expression of guidance cues and 
their cellular receptors play an important part in guiding an axon towards its target and assist in 
synaptogenesis (Martinez et al., 1998; Kaprielian et al., 2001; Martinez et al., 2005; Dickson and 
Gilestro, 2006; Mendes et al., 2006). We do not know for our system whether NOS or the 
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presence of its cellular target sGC is developmentally regulated. Studies in the snail Ilyanassa 
obsoleta reported an upregulation of NOS in the developing nervous system during the larval 
stage, followed by a down regulation through metamorphosis (Lin and Leise, 1996; 
Thavaradhara and Leise, 2001). The developmental regulation of both NOS and sGC in the 
enteric nervous system of the locust serve as a impressive example of how differential expression 
may be useful in establishing the early migratory outcome of cells along the midgut (Haase and 
Bicker, 2003; Bicker, 2005; Bicker, 2007).  
We have presented data that demonstrate that NO donors applied to neurons grown in cell 
culture can affect growth cone motility and it is reasonable to assume that NO might influence 
neuronal pathfinding in vivo. Our observation that NO resulted in filopodial elongation and a 
slow-down in growth cone advance, a response we termed ‘slow down and search’ behavior, 
could indicate a role for NO as a stop signal in the target region prior to synaptogenesis. NOS 
has been localized in target regions in several systems and its expression correlated with 
synaptogenesis (Roskams et al., 1994; Williams et al., 1994; Ogilvie et al., 1995). Recent studies 
reported that presynaptic plasticity induced during activity-dependent synaptogenesis was 
regulated by NO (Nikonenko et al., 2003; Zhang et al., 2005). Moreover, there is evidence that 
NO regulates the activity dependent refinement of retinal projections. Inhibition of nNOS by 
pharmacological blockers was shown to prevent the elimination of transient ipsilateral 
retinotectal projections in the chick visual system, and to affect retinogeniculate projection 
patterns in ferret (Wu et al., 1994; Cramer and Sur, 1999).  
In conclusion, we have demonstrated that spontaneous NO release from a single neuron 
has physiological effects on the dynamics of growth cones growing in its vicinity, and that this 
effect is mediated through the canonical target of NO, namely sGC. These results strongly 
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suggest a potential role for NO as a modulator of growth cone motility during neuronal 
pathfinding and synaptogenesis in vivo. 
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Chapter 4 : Research Published in Collaboration: PLA2 and Secondary Metabolites of 
Arachidonic Acid Control Filopodial Behavior in Neuronal Growth Cones 
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Abstract  
The neuronal growth cone provides the sensory and motor structure that guides neuronal 
processes to their target. The ability of a growth cone to navigate correctly depends on its 
filopodia, which sample the environment by continually extending and retracting as the growth 
cone advances.  Several second messengers systems that are activated upon contact with 
extracellular cues have been reported to affect growth cone morphology by changing the length 
and the number of filopodia.  Because recent studies have suggested that guidance cues can 
signal via G-protein coupled receptors to regulate phospholipases, we here investigated whether 
phospholipase A2 (PLA2) may control filopodial dynamics and could thereby affect neuronal 
pathfinding. Employing identified Helisoma neurons in vitro we demonstrate that inhibition of 
PLA2 with 2 M BPB caused a 40.3% increase in average filopodial length, as well as a 37.3% 
reduction in the number of filopodia on a growth cone. The effect of PLA2 inhibition on 
filopodial length was mimicked by the inhibition of G-proteins with 500 ng/ml pertussis toxin 
and was partially blocked by the simultaneous activation of PLA2 with 50nM melittin.  We 
provide evidence that PLA2 acts via production of arachidonic acid (AA), because (a) the effect 
of inhibition of PLA2 could be counteracted by supplying AA exogenously, and (b) the inhibition 
of cyclooxygenase, which metabolizes AA into prostaglandins also increased filopodial length. 
We conclude that filopodial contact with extracellular signals that alter the activity of PLA2 can 
control growth cone morphology and may affect neuronal pathfinding by regulating the sensory 
radius of navigating growth cones. 
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Introduction  
Phospholipase A2 (PLA2) is a group of enzymes that catalyze the breakdown of 
phospholipids.  They are activated by signaling through calcium (van den Bosch, 1980), kinases 
(Lin et al., 1993), growth factors (Spaargaren et al., 1992), or through metabotropic receptors, 
such as glutamate receptors (Dumuis et al., 1993). The mechanism by which G-proteins activate 
PLA2 is unclear, as activation has been reported to occur through an unknown G-protein 
(Tsunoda and Owyang, 1994) or the activity of Gi (Dickerson and Weiss, 1995). While PLA2 
plays a role in membrane maintenance and breakdown (Bonventre, 1992), it also produces a 
number of active messengers with wide ranging cellular functions (Axelrod, 1990). PLA2 cleaves 
phospholipids, thereby producing arachidonic acid (AA) and lysophospholipids (Negre-Aminou 
and Pfenninger, 1993).  Messengers produced by PLA2 activity have been demonstrated to affect 
neurite advance, as inhibition of PLA2 decreases outgrowth in dorsal root ganglion neurons from 
the adult frog (Edstrom et al., 1996) and mouse (Hornfelt et al., 1999). In addition, PLA2 is 
localized to rat nerve growth cones (Negre-Aminou et al., 1996) and is necessary for growth 
cone formation (Geddis and Rehder, 2003). Finally, PLA2 is involved in thrombin-induced (de 
La Houssaye et al., 1999) and semaphorin 3A-induced (Mikule et al., 2002) growth cone 
collapse. Taken together, the involvement of PLA2 in neurite outgrowth and its localization to the 
growth cone suggest that it may play an important role in generating growth cone behavior.  
In the developing nervous system, neuronal growth cones navigate through a complex 
environment in order to make appropriate synaptic connections. Filopodia have been shown to be 
of critical importance in this process, as growth cones stripped of their filopodia are impaired in 
their pathfinding abilities (Bentley and Toroian-Raymond, 1986). Receptors on filopodia contact 
cues ahead of the growth cone proper, and the ability of filopodia to undergo length changes 
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provides a growth cone with the capability to adjust its action radius according to the particular 
pathfinding situation.  The detection of extracellular cues by receptors on filopodia is thought to 
activate intracellular signals that control growth cone behavior such as growth cone advance 
(Nakamura et al., 2000) and steering (O'Connor et al., 1990). It has been reported previously that 
intracellular signaling molecules such as phosphatases, kinases and calcium are involved in 
controlling growth cone behavior in identified Helisoma neurons (Davenport and Kater, 1992; 
Rehder and Kater, 1992; Welnhofer et al., 1999). Whereas our knowledge of the signaling 
mechanisms downstream of extracellular ligands such as semaphorins, netrins and certain growth 
factors (such as EGF and NGF) is increasing rapidly (Handler et al., 1990; Weisenhorn et al., 
1999; Segal, 2003), we know very little about the potential role of lipid-derived messengers in 
regulating growth cone behavior.  
Given the central role played by filopodia in growth cone navigation, this study 
investigates mechanisms by which phospholipase A2-mediated second messengers control 
filopodial dynamics. A pharmacological approach is employed to demonstrate that PLA2 activity 
regulates filopodial length and number through the production of arachidonic acid and two of its 
products, prostaglandins and leukotrienes. Therefore, guidance cues which signal through PLA2 
should be considered as potential candidates to direct the outcome of neuronal pathfinding. 
 
Methods and Materials  
Neuronal culture and imaging 
Identified B5 neurons were dissected from Helisoma trivolvis buccal ganglia and plated 
for neuronal culture.  Neurons were plated onto a poly-L-lysine-(hydrobromide, MW 70,000-
150,000, 0.25 mg/ml, Sigma, St. Louis, MO) coated glass coverslip glued to the bottom of a 35 
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mm cell culture dish.  Cells were allowed to grow overnight at room temperature and used 24-48 
hours after plating.  Cells were grown in conditioned medium prepared by incubating snail brains 
in Leibowitz L-15 medium (special order, Gibco, Grand Island, NY) modified to a final 
concentration of: 40 mM NaCl, 1.7 mM KCl, 1.5 mM MgCl2, 4.1 mM CaCl2, 10 mM HEPES, 
50 g gentamycin/ml, 0.15 mg glutamate/ml in distilled water (pH = 7.3).  Growth cones were 
viewed under a 100x oil immersion objective on an Axiovert (Carl Zeiss, Thronwood, NY) or a 
Sedival (aus Jena, Germany) microscope.  Images were captured with a cooled CCD (CH250, 
Photometrics, Tucson AZ) or C-72 camera (MIT Dage, Michigan City, IN) interfaced with NIH 
image software (Wayne Rasband, NIH).  The images were viewed and analyzed on a Power 
Macintosh (Apple Computer, Cupertino, CA).  
 
Pharmacological treatments  
Observation of growth cone behavior, specifically changes in filopodial length and number, 
was performed at defined times before and after the addition of pharmacological agents, which 
were added through a complete medium exchange.  Images were captured before (-5 and 0 min) 
and at defined times after (2, 5, 10, 15, 20, 30 minutes) a complete medium exchange, which 
introduced the experimental condition.  A complete medium exchange was accomplished by 
removing all medium from the dish, except from the center well formed by the coverslip attached 
to the dish (approximate volume: 200 µl), and by adding 2 ml of L-15 medium containing the 
premixed drug. The phospholipase 2A (PLA2) inhibitors, 4-bromophenacyl-bromide (BPB) was 
obtained from Sigma and dissolved to stock concentrations of 2.5 mM in warm methanol.  All 
other drugs were purchased from Calbiochem (La Jolla, CA). The cyclooxygenase (COX-2) 
inhibitor, diclofenac sodium{2-[(2’,6’-Dichlorophenyl)amino] benzeneacetic Acid, Na} 
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 was dissolved in water to a stock concentration of 5 mM. Cytochalasin B (Helminthosporium 
dematioideum) was dissolved in DMSO to a stock concentration of 4 mM, and arachidonic acid 
(porcine liver, sodium salt) was dissolved in water to a stock concentration of 200 mM. Control 
experiments were performed by addition of the solvents used for the reconstitution of the 
pharmacological agents above. 
 
Data analysis and statistics 
Growth cone behavior was assessed by determining the change in filopodial length and 
number as previously described (Van Wagenen and Rehder, 1999). By using fiduciary markers 
present in the dish, filopodial elongation was measured as active protrusion of filopodial tips and 
thus ruled out “apparent” elongation, which can result from lamellipodial retraction. Values are 
expressed as mean ± SEM. Significance between conditions was determined by performing an 
analysis of variance (1-way ANOVA or ANOVA with time as repeated measure) with 
SuperANOVA (Abacus Concepts, Berkeley, CA).  Fisher’s Protected Least Significant 
Difference (PLSD) test was used for post-hoc tests of statistical significance.  Significant 
differences are indicated as: *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. 
 
Results 
Filopodial length is controlled by PLA2 activity through arachidonic acid and its secondary 
metabolites 
To examine how phospholipase 2A (PLA2) may affect filopodial length, and by 
extension, the action radius of a navigating growth cone, the activity of PLA2 was inhibited by 
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the addition of the specific PLA2 inhibitor 4-bromophenacyl-bromide (BPB). 2 M BPB 
induced an increase in filopodial length (Fig. 4.1). To investigate further the pathway by which 
PLA2 mediated its effect on filopodial behavior, we examined first the role of AA, the major 
product of PLA2 activity, and then key enzymes metabolizing AA (Fig. 4.2). If PLA2 acted 
through AA, then it should be possible to interfere with the effect of PLA2 inhibition by 
providing AA through alternative sources. AA can be taken up by cells grown in cell culture 
when added to the extracellular medium (Piomelli et al., 1987; Carlson and Levitan, 1990). 
Extracellularly applied AA (5 µM) had no significant effect on filopodial length when added by 
itself (Fig. 4.2), but it significantly reduced the effect of BPB (2µM) on filopodial length when 
BPB was applied after cells had been preincubated with AA (5µM) for 5 minutes (p < 0.05), 
supporting the hypothesis that PLA2 acted via AA. AA is the substrate of two enzymes that 
produce different eicosanoid messengers (Funk, 2001). AA is converted into leukotrienes by the 
action of lipoxygenase and into prostaglandins by cyclooxygenase (Fig. 4.2). If PLA2 acted 
through one of these pathways, inhibition of these pathways should mimic the inhibition of PLA2 
itself.  Indeed, inhibition of cyclooxygenase with diclofenac sodium (100 M) caused filopodial 
elongation (Fig. 4.3B). Quantification of this effect showed that filopodial length was elevated 
by 28.3 ± 3.1% as early as five minutes after cyclooxygenase inhibition.  
 
PLA2 and cyclooxygenase affect filopodial dynamics 
Because filopodia are composed of bundled f-actin (Gordon-Weeks, 1987), and filopodial 
length changes are to a large part dependent on actin polymerization and depolymerization 
events, we started to investigate whether PLA2 inhibition might affect actin dynamics and 
thereby lead to filopodial elongation. To address the question whether filopodial elongation was  
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Figure 4.1: The effect of inhibition of PLA2 on filopodial behavior is mediated through 
arachidonic acid.  
Inhibition of PLA2 with BPB (2 µM) elicited filopodial elongation of 28.6 ± 4.3% five minutes 
after treatment, and this effect was significantly blocked to 15.6 ± 3.5% when neurons were 
pretreated for 5 minutes with 5 µM AA added to the medium (p < 0.05). The same concentration 
of AA added alone had no significant effect on filopodial length. 
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Figure 4.2: Mechanisms of PLA2 activation and pathways downstream of PLA2 involved in 
controlling filopodial dynamics.  
Activation of PLA2 can occur through G-protein coupled receptors or an increase in [Ca2+]i. 
PLA2 cleaves phospholipids to produce arachidonic acid (AA) which, in turn, is converted into 
prostaglandins and leukotrienes by cyclooxygenase and lipoxygenase, respectively. Inhibition of 
PLA2 resulted in distinct changes in growth cone behavior, namely filopodial elongation and a 
reduction in the number of filopodia. AA and its secondary metabolites control filopodial 
dynamics through the action of leukotrienes and prostaglandins. The mechanisms by which 
leukotrienes and prostaglandins affect filopodial dynamics is presently unknown and symbolized 
by a black box. 
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Figure 4.3: Filopodial elongation resulting from inhibition of PLA2 and cyclooxygenase 
involves actin polymerization.  
(A) The effect of filopodial elongation observed after 5 minutes of inhibition of PLA2 with BPB 
(2 µM) was completely blocked when growth cones were preincubated for 10 minutes with 30 
nM cytochalasin B (Cyto B, p ≤ 0.001). The same concentration of cyto B added alone had no 
effect on filopodial length. (B) Inhibition of cyclooxygenase with diclofenac Na+ (100 µM) 
resulted in an increase in average filopodial length to 28.3 ± 3.1% after 5 minutes of treatment. 
This effect was significantly blocked to 5.1 ± 3.6% when growth cones were preincubated with 
30 nM cyto B for 10 minutes (p ≤ 0.001) before the addition of diclofenac Na+ (100 µM). 
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the result of actin polymerization, growth cones were incubated in cytochalasin B (cyto B, 30 
nM) for 10 minutes before adding BPB (2µM). Cytochalasin inhibits actin monomer addition 
to the plus end of microfilaments and at this low concentration had no effect on filopodial length 
(Fig. 4.3A). When BPB was added in the presence of cyto B, however, the effect of BPB was 
completely inhibited (p ≤0.001), suggesting that the BPB-induced filopodial elongation resulted 
from actin polymerization. We next investigated if the elongation observed upon inhibition of 
cyclooxygenase with diclofenac sodium was also due to actin polymerization. Whereas 
diclofenac sodium had its maximal elongation effect as early as 2 minutes after addition, this 
effect was completely blocked when the drug was added after growth cones had been incubated 
in cyto B for 10 minutes (p ≤ 0.001; Fig. 4.3B).  
 
Discussion 
Growth cones are guided by receptors that interact with various guidance cues (Tessier-
Lavigne and Goodman, 1996). Ligand-receptor interactions activate particular second messenger 
systems that cause directed changes in the growth cone’s cytoskeleton (Gallo and Letourneau, 
2000), which ultimately translate into growth cone steering events. Although there is a 
considerable body of knowledge describing the role of kinases on growth cone behavior (Jian et 
al., 1994; Bonsall and Rehder, 1999; Cheng et al., 2000) and neuronal guidance (Jian et al., 
1994; Burden-Gulley et al., 1997; O'Leary and Wilkinson, 1999; Wills et al., 2002), we know 
very little about the potential role of lipid-derived messengers in regulating growth cone 
behavior. Lipid-derived messengers can be activated by extracellular ligands through various G-
protein-coupled receptors (Rozengurt, 1991; Roberts, 1996; Funk, 2001), but their effects on 
growth cone motility and subsequent neuronal pathfinding have not been well studied.  We here 
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describe the effects of a prominent class of phospholipases, PLA2, on the regulation of growth 
cone filopodia. The data presented suggest that the activity of PLA2 and its downstream products 
affect growth cone behavior and could function in the signal transduction cascade from 
extracellular guidance cues to the actin-based cytoskeleton.  
 
Inhibition of PLA2 causes filopodial elongation and a reduction in filopodial number  
In the presence of the PLA2 inhibitor BPB, the mean filopodial length on growth cones 
increased rapidly and filopodia remained elongated for at least 30 minutes. The long-term effects 
on filopodia seen with PLA2 inhibition may be due to the fact that BPB is known to bind PLA2 
irreversibly (Roberts et al., 1977). Under physiological circumstances, a transient inhibition of 
PLA2 activity would be expected to cause short-term filopodial elongation. Such a response 
would result in a rapid and transient increase in the action radius of a growth cone and allow it to 
survey a larger area during pathfinding.  
Filopodia contain bundled f-actin and theoretically, filopodial length can be controlled by 
actin polymerization and depolymerization rates, as well as by altering the rate of retrograde 
actin flow. The experiments in which actin polymerization was inhibited by cytochalasin 
suggested that filopodial elongation observed under PLA2 inhibition resulted from actin 
polymerization. After approximately 10 minutes of PLA2 inhibition, filopodia stopped 
elongating. This second, longer-term effect of PLA2 inhibition, at which filopodia appeared 
somewhat “frozen”, suggested that eventually the mechanism(s) that result(s) in further 
filopodial elongation were both inhibited. Our results are consistent with the interpretation that 
PLA2 activity is necessary for both filopodial extension and retraction to occur. The notion that 
PLA2 activity might be required for actin depolymerization is supported by the result that PLA2 
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is necessary for thrombin-induced growth cone collapse (de La Houssaye et al., 1999). Because 
our experimental approach did not allow us to differentiate fully between effects of PLA2 on 
retrograde flow, or on the barbed and pointed ends of f-actin, future studies will be needed to 
determine which of these mechanisms, or which combination of mechanisms, is responsible for 
the filopodial elongation observed in these experiments.  
 
Inhibiting the production of AA and its secondary metabolites alters actin dynamics 
 Our finding that the extracellular addition of AA was able to decrease the effect of PLA2 
inhibition and partially blocked filopodial elongation, suggested that PLA2 indeed acted through 
AA. AA has been shown to be taken up by cells (Carlson and Levitan, 1990; Piomelli et al., 
1987) and it has to be assumed that the external application of AA increased the intracellular 
[AA] such that the inhibition of PLA2, resulting in a reduction of AA production from 
phospholipids, had a lesser effect on the overall concentration of AA in the cell. Our attempts to 
fully block the effect of PLA2 inhibition by providing extracellular AA was unsuccessful, 
because higher concentrations of AA applied externally caused filopodial lengthening itself (data 
not shown), potentially due to its effect of raising [Ca2+]i as has been demonstrated for AA in 
other cell types (Williams et al., 1994; Roudbaraki et al., 1995). 
It has been reported that the products of cyclooxygenase and lipoxygenase activity, 
prostaglandins and leukotrienes, work to control actin dynamics. For example, in fibroblasts, 
cyclooxygenase inhibitors increase actin polymerization, whereas lipoxygenase inhibitors are 
reported to decrease actin polymerization (Peppelenbosch et al., 1993). The former effect is 
consistent with our results in which the inhibition of prostaglandin production induced filopodial 
elongation. As suggested by its blockage in the presence of cytochalasin, this filopodial 
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elongation resulted from actin polymerization and suggested that PLA2 could control actin 
dynamics via AA production in Helisoma neurons as well. Therefore, the role of PLA2 in 
mediating growth cone behavior may be to produce AA that is further metabolized into 
leukotrienes and prostaglandins, which in turn potentiate the cell’s ability to extend and retract 
its filopodia through actin polymerization/ depolymerization events.  
 
A role for phospholipases in neuronal pathfinding? 
Elucidation of the signaling pathways involved in controlling filopodial dynamics will lead to 
a better understanding of how neuronal growth cones traverse the terrains encountered during 
pathfinding. In this study we have used a pharmacological approach to demonstrate that the 
PLA2 signaling pathway in growth cones affects filopodial behavior by altering filopodial length. 
To our knowledge, this study is the first to implicate PLA2 and the secondary metabolites of AA 
in the process of filopodial regulation. Whereas the effects described here occurred on a time 
scale of minutes, taken together with findings by others that PLA2 inhibition reduces the rate of 
neurite outgrowth on a longer time scale, a picture emerges that PLA2 inhibition may signal the 
transformation of a growing growth cone into one that extends its filopodia and then slows down 
to initiate a searching behavior, as is seen in growth cones that undergo pathfinding decision in 
vivo. We restricted our pharmacological experiments to 30 minutes, because we assume that 
signaling events mediated through the activation or inhibition of second messenger pathways are 
likely to be most effective when they are of short duration, and because effects arising from long 
term stimulation are inherently more difficult to interpret. Taken together, we propose that PLA2 
may be activated by G-protein coupled receptors or by Ca2+ to produce AA. AA is then 
metabolized into leukotrienes and prostaglandins, which act to alter the polymerization and 
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depolymerization state of actin (Fig. 4.1). Future studies of guidance cues and their activation of 
phospholipases, such as PLA2, in migrating growth cones should shed light on the physiological 
role of PLA2 in neuronal pathfinding, as well as further clarify the signaling mechanisms that 
regulate the underlying actin dynamics. 
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Chapter 5 : General Discussion and Conclusions 
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During neuronal pathfinding, growth cones located at the tip of axons and dendrites 
encounter and respond to diffusible and membrane-bound cues along the path toward their 
targets. These extracellular cues trigger intracellular mechanisms regulating growth cone 
cytoskeletal dynamics that are important for correct pathfinding and successful synaptogenesis. 
Although many molecules and signaling pathways linking guidance cues to changes in growth 
cone cytoskeletal dynamics have been characterized, the aim of this dissertation is to extend our 
knowledge of mechanisms controlling growth cone morphology via two main studies: (1) To 
examine how PI-3K affects growth cone dynamics and the identification of its intracellular 
signaling pathway, and (2) To examine how neuronal NO release can influence the physiology of 
other neurons nearby, with a focus on effects of NO release on growth cone dynamics.  
 
Molecules and Mechanisms Controlling Growth Cone Dynamics and Motility 
Signaling pathways 
Growth cones, defined as both sensory and motor structures, are comprised of a central 
domain, composed of microtubules and organelles, and lamellipodia and filopodia, which are 
composed of meshworks and bundles of F-actin filaments, respectively (Smith, 1988; Huber et 
al., 2003). Filopodia continuously extend and retract to sample and respond to their environment 
during their journey toward their targets, and by doing so, adjust the area they sense at any given 
point in time, referred to as the “action radius”. Actin-based filopodial dynamics are critical for 
correct pathfinding: elimination of actin dynamics and subsequent loss of filopodia from 
embryonic grasshopper pioneer growth cones by treatment with the actin depolymerizing agent 
cytochalasin leads to misguidance of pioneer neurites (Bentley and Toroian-Raymond, 1986). 
Treatment of Xenopus retinal growth cone with cytochalasin induces misguidance as well (Chien 
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et al., 1993). Because filopodia are necessary for correct guidance and therefore the proper 
wiring of the nervous system, understanding the mechanisms controlling their dynamics is 
critical. Many molecules and second messengers have been identified, but critical gaps in 
signaling pathways still remain. The current work contributes to a better understanding of growth 
cone morphology by studying how a molecule, PI-3K, and its downstream targets (ROCK, Akt 
and MEK) regulate this process. 
Calcium has been demonstrated to be critical for growth cone behavior (Kater et al., 
1988; Kater and Mills, 1991; Henley and Poo, 2004). In Helisoma growth cones, an increase in 
the intracellular calcium concentration [Ca2+]i induces an increase in filopodial length (Davenport 
and Kater, 1992; Rehder and Kater, 1992). An increase in filopodial length was also observed 
after global and regional release of calcium, via uncaging, in growth cones (Cheng et al., 2002). 
Calcium also regulates neurite outgrowth (Nishi and Berg, 1981; Mattson and Kater, 1987) and 
growth cone steering (Henley and Poo, 2004). Growth cone turning induced by a directed source 
of a guidance cue is mediated by a local increase in [Ca2+]i on the side stimulated by the cue 
(Song and Poo, 1999; Hong et al., 2000; Henley and Poo, 2004). Downstream targets of calcium 
that regulate growth cone dynamics have also been identified. The effect of an increase in [Ca2+]i 
on the Helisoma B5 growth cone is mediated by calmodulin and the calcium-dependent 
phosphatase, calcineurin (Cheng et al., 2002), suggesting that the phosphorylation state of the 
growth cone regulates filopodial dynamics.  
In vivo and in vitro studies have demonstrated that kinases and phosphatases regulate 
growth cone guidance (Elkins et al., 1990; Williams et al., 1994; Callahan et al., 1995; Gallo et 
al., 1997). Treatment of Helisoma B5 growth cones with the general protein kinase inhibitor 
K252A and specific inhibitors of protein kinase C (PKC) result in an increase in filopodial length 
 128
and a decrease in filopodial number (Cheng et al., 2000). Consistent with the above evidence, 
our results provide new information about another protein kinase, phosphatidylinosotol-3-kinase 
(PI-3K), and its downstream targets as regulators of growth cone dynamics (Tornieri et al., 
2006). Because PKC is a downstream target of PI-3K (Krasilnikov, 2000), our finding that PI-3K 
inhibition induces an increase in filopodial length confirms our previous work suggesting a role 
of PKC in regulating filopodial behavior (Cheng et al., 2000). This effect of PI-3K regulating 
growth cone morphology also supports previous studies demonstrating a role of PI-3K in neurite 
outgrowth (Kita et al., 1998; Ditlevsen et al., 2003). In addition PI-3K has been demonstrated to 
mediate ephrin A5 and slit-2 induced growth cone collapse in chick retinal ganglion cells (Wong 
et al., 2004). Recently our PI-3K results were supported by a study that demonstrated that 
neurotrophins regulate dendritic filopodial dynamics in mouse hippocampal cultures through PI-
3K (Luikart et al., 2008). In addition to providing the first demonstration of the regulation of 
growth cone dynamics by PI-3K, our work also unraveled the mechanisms by which PI-3K 
might regulate growth cone guidance. We have shown that PI-3K affects filopodial dynamics 
through its double enzymatic activity, namely its lipid kinase and protein kinase activities. Our 
finding that inhibition of Rho-activated protein kinase (ROCK) causes filopodial elongation 
confirms a report on retinal ganglion neurons in which filopodial elongation was elicited by 
inhibition of the ROCK effector RhoA, and ROCK itself (Gehler et al., 2004; Gehler et al., 
2004). Taken together, our work demonstrates a role for PI-3K kinase in regulating growth 
cone dynamics during neuronal pathfinding via both its lipid and protein kinase activities.  
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Filopodial dynamics 
 Filopodia are continuously going through cycles of extension and retraction. Thus, 
overall filopodial elongation can be explained by changes in dynamic parameters, such as the 
rate at which filopodia extend and retract, as well as the amount of time that an individual 
filopodium spends extending, retracting or not moving. Our laboratory has previously 
demonstrated that NO-induced filopodial elongation is achieved by increasing the rate at which 
filopodia elongate and the time that individual filopodia spend extending (Van Wagenen et al., 
1999). The results of changes in filopodial dynamic parameters are supported by our findings 
that the filopodial elongation observed after inhibition of PI-3K is also mediated by a 
combination of an increase in the extension rate and the time that filopodia spend extending 
(Chapter 2). Possible changes in cytoskeletal dynamics explaining these modifications of 
filopodial dynamic parameters will be explained in detail later in the discussion. It will be of 
interest in the future to investigate if these changes in filopodial dynamic parameters constitute a 
general mechanism mediating growth cone filopodial extension or if they are specific to 
particular signaling pathways.  
 
Physiological effect of NO on growth cone dynamics 
The gaseous messenger nitric oxide (NO) has been demonstrated to regulate different 
processes in the nervous system, including development, synaptic plasticity, cell death and 
neurogenesis (Ernst et al., 1999; Lipton, 1999; Contestabile and Ciani, 2004; Matarredona et al., 
2005; Bicker, 2007). The fact that NO is a gas makes it an unconventional messenger, which can 
diffuse across cell membranes and affect target molecules in neighboring cells. In the nervous 
system, NO is formed by the conversion of L-arginine and oxygen to L-citrulline by 
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calcium/calmodulin-dependent neuronal nitric oxide synthase (nNOS) (Alderton et al., 2001). 
Previous studies in B5 Helisoma neurons demonstrated that global application of NO donors 
induces an increase in filopodial length and a decrease in neurite outgrowth in vitro (Van 
Wagenen et al., 1999; Trimm and Rehder, 2004), suggesting a role for NO as a guidance cue 
regulating neuronal pathfinding. This role of NO was further supported by a recent finding that 
focal application of NO onto a single growth cone induces an increase in filopodial length locally 
on the stimulated growth cone via soluble guanylyl cyclase (sGC), protein kinase G (PKG), 
cyclic adenosine diphosphate ribose (cADPR) and intracellular calcium release from ryanodine 
sensitive stores (Welshhans and Rehder, 2005; Welshhans and Rehder, 2007).  
However, this work examines the ultimate demonstration of a role for NO in affecting 
growth cone motility, by studying the effect of physiological concentrations of NO on growth 
cone dynamics. Although both NO release from NO-donors and single cells induces an increase 
in filopodial length, the duration of this effect differs. Global stimulation with the NO donor 
SIN-1, results in a long-term stimulation and induces a rapid and transient increase in filopodial 
length followed by a sustained plateau during which filopodia remain elongated over control 
values (Van Wagenen et al., 1999; Van Wagenen and Rehder, 2001). Local and short term 
stimulation with the NO donor NOC-7 causes a transient increase in filopodial length lasting 
approximately 20 minutes (Welshhans and Rehder, 2005; Welshhans and Rehder, 2007). 
Stimulation by a single cell, which continuously releases NO and results in long term 
stimulation, caused filopodial elongation and filopodia remained elongated in the presence of the 
stimulating cell (Tornieri and Rehder, 2007). These results suggest that the duration of the NO 
stimulation influences the time filopodia remain extended. Our finding that NO release from a 
single cell affects growth cone morphology of neighboring growth cones entering the “plume” of 
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NO strongly confirms a paracrine role of NO in regulating growth cone dynamics (Tornieri and 
Rehder, 2007). This concept of NO acting in a paracrine fashion was demonstrated during the 
development of the grasshopper embryo, where NO released from epithelial cells facing the 
basal lamina of the antenna regulates axonal pathfinding of antennal pioneer neurons (Seidel and 
Bicker, 2000; Bicker, 2007).  
The fact that NO has a very short half-life, and the finding that NO release from a single 
cell affects filopodial length with the same intensity as stimulation with NO donors suggests that 
low concentrations of NO can have strong physiological effects on growth cone morphology. 
These strong changes in filopodial dynamics may be explained by amplification of spatial and 
temporal stimulation by NO through its signaling pathway, or that the system is very sensitive to 
begin with and is saturated easily. This effect of a low concentration of NO on filopodial length 
is also observed when NO is temporally and spatially applied on B5 growth cones for 
milliseconds with a picospitzer (Welshhans and Rehder, 2005). This strong effect on growth 
cone dynamics may be explained by the fact that binding of NO to the heme group of sGC 
increases its catalytic activity by a hundred fold (Bellamy et al., 2002; Russwurm and Koesling, 
2004). It has been demonstrated that physiological NO concentrations in the brain are in the low 
nanomolar range (Hall and Garthwaite, 2006). NO sensing electrodes and fluorescent dyes such 
has DAF-2A have been used to detect NO release from tissues and cells within tissues 
(Friedemann et al., 1996; Bedioui et al., 1997; Kojima et al., 1998). Recently, detection of NO 
release from single neurons has been performed in the isolated CNS of Lymnaea stagnalis by 
using multiple film coated electrode sensors (Patel et al., 2006). Furthermore, picomolar 
concentrations of NO released from single epithelial cells and hippocampal neurons were 
detected by a cell-based indicator (Sato et al., 2006). Detection and quantification of NO released 
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from single B5 senders will be important to investigate in the future. Our study with the sender-
receiver paradigm demonstrates that B5 neurons spontaneously produce NO and that NO has 
physiological effects on neighboring growth cones up to a distance of 100 µm away from the 
sender cell. This finding provides crucial physiological information to previous modeling studies 
of NO release, which have demonstrated a diffusion radius of approximately 200 µm from a 
point source of NO (Lancaster, 1994; Wood and Garthwaite, 1994; Lancaster, 1997). Our 
finding provides the first demonstration that physiological concentrations of NO affect 
filopodial dynamics and strongly suggests a role of NO as a modulator of growth cone 
motility during neuronal pathfinding in vivo. 
 
Paracrine versus autocrine role of NO  
The fact that B5 neurons express both nNOS and the NO target, soluble guanylyl cyclase 
(sGC) (Van Wagenen and Rehder, 2001), make them unique in that they produce NO and also 
can respond to it. Therefore, we can speculate that in addition to responding to NO release from 
neighboring cells during pathfinding B5 neurons may also intrinsically produce NO to regulate 
aspects of their own physiology. Indeed, inhibition of endogenous NOS in B5 neurons induces a 
slow-down in the rate at which neurites advance (Trimm and Rehder, 2004), suggesting that their 
own source of NO is necessary for a normal outgrowth rate, and down- or up-regulation of NO 
production may be an intrinsic mechanism to regulate neurite advance. In our study investigating 
the effect of NO release from a single cell on growth cone dynamics, inhibition of endogenous 
production of NO in B5 receivers with the specific NOS inhibitor 7-NI had no effect on 
filopodial dynamics (Tornieri and Rehder, 2007). This result suggests that endogenous NO may 
regulate neurite outgrowth by a mechanism independent from that regulating filopodial length. 
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Because nNOS is activated by calcium/calmodulin, one possible mechanism to regulate the 
amount of endogenous NO production could be through changes in the intracellular calcium 
concentration, which is modulated by neuronal activity. It will be of interest in the future to 
investigate if there is an interaction between endogenous and exogenous NO, with the rationale 
that the amount of spontaneously produced NO may modulate the response of the cell to 
exogenous NO. The fact that (1) NO signaling leads to an increase in [Ca2+]i (Van Wagenen and 
Rehder, 1999), and (2) [Ca2+]i regulates neurite outgrowth based on the calcium set point 
hypothesis (Kater and Mills, 1991), allows one to envision a scenario in which endogenously 
produced NO helps to ‘set’ the [Ca2+]i which can be further modulated by exogenous NO to 
regulate growth cone behavior and neurite outgrowth. Modulation in the [Ca2+]i has been shown 
to have striking effects on growth cone behavior, such as in the case of Xenopus spinal neurons, 
where changes in the amplitude of total [Ca2+]i elevation were demonstrated to convert growth 
cone steering from attraction to repulsion (Zheng, 2000). 
 
Interaction between Filopodial Length, Number and Neurite Outgrowth 
Slow down and search behavior 
As mentioned earlier, filopodia on growth cones are motile and sensing structures crucial 
for correct neuronal pathfinding. Although many studies have established the mechanisms by 
which filopodial dynamics govern growth cone behaviors, such as collapse and steering, the 
relationship between filopodial length and neurite outgrowth is still poorly understood. During 
their journey toward their targets and depending on their position in the environment, growth 
cone morphology and neurite outgrowth vary. Growth cones tend to have an elongated shape 
without any filopodia and advance at a fast rate when they grow along an already established 
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path laid down by other axons; whereas when growth cones are at decision points, filopodial 
length increases and the speed of neurite advance decreases (Tosney and Landmesser, 1985; 
Bovolenta and Mason, 1987; Godement et al., 1994; Kuhn et al., 1995; Trimm and Rehder, 
2004). The latter has been referred to as a “slow down and search” behavior (Trimm and Rehder, 
2004). The benefit of this behavior for a navigating growth cone would be to enhance its sensory 
ability: (i) by increasing its action radius through filopodial elongation, and (ii) by increasing the 
duration of its exploration of the environment.  
This slow down and search behavior was also observed following inhibition of PI-3K. 
Interestingly, inhibition of either ROCK or Akt, two downstream targets of PI-3K, allowed us to 
separate the slow down and search behavior into a “search” and a “slow down” component 
(Tornieri et al., 2006). We can envision that during pathfinding in vivo, depending on the 
signaling pathway activated by guidance cues or the intensity of the stimulation, navigating 
growth cones may increase their action radius and continue to advance at the same speed 
(“search”) or, alternatively, increase their action radius and decrease or stop their advance (“slow 
down and search”). Because of technical issues, neurite outgrowth could not be investigated in 
our study using the sender-receiver paradigm, however, a previous publication from our 
laboratory demonstrated that NO induces a concomitant increase in filopodial length and a 
decrease in neurite outgrowth (Trimm and Rehder, 2004). The concept that the same signaling 
molecule may affect filopodial dynamics and neurite outgrowth is further supported by findings 
from multiple studies demonstrating that protein kinases affect both growth cone behavior and 
neurite outgrowth (Bixby, 1989; Bixby and Jhabvala, 1992; Oberstar et al., 1997; Cheng et al., 
2000)  
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Calcium and growth cone dynamics 
Calcium has been demonstrated to be a critical regulator of growth cone behavior, with 
an increase in [Ca2+]i leading to filopodial elongation and a decrease in filopodial number (Kater 
and Mills, 1991; Rehder and Kater, 1992). However, filopodial elongation induced by inhibition 
of PI-3K is not mediated by an increase in [Ca2+]i, suggesting that the slow down and search 
behavior can be elicited by a calcium-independent mechanism as well (Tornieri et al., 2006). 
Furthermore these findings suggest that a calcium-dependent signaling event, like NO signaling, 
and a calcium-independent signaling event may converge on the same target to affect actin 
cytoskeleton dynamics and therefore elicit the same effect on filopodial dynamics and neurite 
outgrowth. Actin binding proteins (ABPs), such as cofilin and gelsolin, are good candidates for 
convergence targets, as they have been shown to be regulated by calcium, 
phosphatidylinositolphosphates and their phosphorylation state (Schafer et al., 1996; Meberg et 
al., 1998; Sun et al., 1999). The involvement of these ABPs in filopodial dynamics will be 
discussed in detail later in the discussion. However we cannot exclude the alternative possibility 
that the absence of measurable changes in [Ca2+]i after PI-3K inhibition could be due to a 
limitation in the sensitivity of the calcium indicator dye. This explanation is in agreement with 
our finding that NO release from a single cell induces filopodial elongation without measurable 
changes in the [Ca2+]i, as opposed to elongation induced by NO donors. Assuming that the 
concentration of NO release in the sender-receiver paradigm is much smaller than the release 
from NO donors, the resulting increase in [Ca2+]i. may not to be detectable but sufficient to affect  
growth cone dynamics. Interestingly, we noticed that treatments that induce filopodial elongation 
without increasing the [Ca2+]i,, such as PI-3K inhibition or NO release from a single cell, do not 
affect filopodial number. The same was observed in a previous study in Helisoma following 
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inhibition of tyrosine kinases and PKC (Cheng et al., 2000). These results suggest that: (i) 
filopodial length can be regulated independently of an elevation in [Ca2+]i or (ii) filopodial length 
is more sensitive to small, possibly undetectable increases in [Ca2+]i than filopodial number. The 
latter is supported by a study in Helisoma, in which a small, local increase in [Ca2+]i by uncaging 
calcium resulted in filopodial elongation but had no effect on filopodial number (Cheng et al., 
2002). This study suggests that a small increase in [Ca2+]i affects filopodial length alone, and not 
filopodial number. 
 
Actin Binding Proteins and Cytoskeletal Dynamics Underlying Changes in Growth Cone 
Filopodia 
Filopodia are composed of bundles of F-actin and any changes in filopodial length will be 
mediated by changes in F-actin dynamics. Filopodial elongation can be explained by three 
mechanisms: (i) an increase in actin polymerization at the barbed end of F-actin, which is located 
at the tip of filopodia, (ii) a decrease in retrograde flow of F-actin, or (iii) a combination of both. 
Our finding that inhibition of actin polymerization with cytochalasin B blocked the filopodial 
elongation induced by PI-3K inhibition (Tornieri et al., 2006), confirms that filopodial length is 
mediated by actin dynamics, and more specifically suggests that inhibition of PI-3K increases 
actin polymerization at the barbed end. Our hypothesis that filopodial elongation is mediated by 
an increase in actin polymerization is further supported by a study in Helisoma, where NO 
donor-induced filopodial elongation was mediated by addition of actin monomers at the barbed 
end (K.Welshhans, personal communication). Because simultaneous inhibition of PI-3K and 
retrograde flow had an additive effect on filopodial elongation, we cannot exclude a role of PI-
3K in regulating retrograde flow. However, our findings that inhibition of PI-3K does not affect 
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filopodial retraction parameters (retraction being thought to be driven by retrograde flow), and 
that a previous study in Helisoma demonstrated that a calcium-induced slow down in retrograde 
flow is dependent on changes in actin bundle dynamics in filopodia (Welnhofer et al., 1999), 
strongly exclude a mechanism involving mainly retrograde flow. The fact that NO-induced 
filopodial elongation is mediated by affecting the rate at which filopodia elongate and the time 
that individual filopodia spend elongating, but had no effect on retraction parameters (Van 
Wagenen et al., 1999), also supports our hypothesis that a slow-down of retrograde flow is not 
the main mechanism involved in filopodial elongation. To summarize, the above findings 
suggest that PI-3K inhibition and application of exogenous NO induce filopodial elongation by 
increasing actin polymerization at the barbed end. Actin polymerization is regulated by actin 
binding proteins (ABPs), which control branching, capping and polymerization. Spatial and 
temporal modification of the activity of these proteins will change the actin dynamics of the 
growth cone cytoskeleton, which is necessary for correct pathfinding.  
There are multiple mechanisms by which PI-3K and NO might regulate F-actin 
extension. The actin binding protein, profilin, controls actin dynamics by binding and 
sequestering actin monomers, leading to the inhibition of actin assembly (Stossel, 1989). 
Phosphatidylinositol-phosphates, such as phosphatidylinositol-3,4-biphosphate (PIP2), have been 
demonstrated to prevent binding of profilin to actin monomers (Goldschmidt-Clermont et al., 
1991; Lu et al., 1996). In addition, phosphorylation of profilin by PI-3K increases its affinity for 
actin monomers (Sathish et al., 2004). Therefore, PI-3K may regulate growth cone dynamics via 
profilin, with the rationale that inhibition of PI-3K increases F-actin polymerization by 
preventing phosphorylation of profilin and by maintaining a high amount of PIP2. This would 
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then lead to an increase in the amount of free actin monomers available for addition at the plus 
end.  
Another ABP, gelsolin, severs actin filaments and prevents actin polymerization onto F-
actin by capping its barbed ends. Gelsolin is regulated by phosphatidylinositol-4,5-biphosphate 
(PIP2) which causes the dissociation of gelsolin from F-actin, and by calcium which promotes 
gelsolin binding to F-actin (Schafer et al., 1996; Sun et al., 1999). It may be that PI-3K inhibition 
induces actin polymerization by increasing the amount of PIP2 available, and therefore 
uncapping gelsolin from barbed ends to promote actin polymerization (Fig. 5.1). Because NO 
induces filopodial elongation by increasing [Ca2+]i, and calcium activates gelsolin, NO may 
mediate its effect on actin polymerization through gelsolin activity. This hypothesis is supported 
by the finding that gelsolin promotes actin polymerization by first severing F-actin and then 
uncapping the newly generated actin filaments (Sun et al., 1999; Yin and Stull, 1999)  
Finally, PI-3K and NO could also regulate actin polymerization via the actin 
depolymerizing factor ADF/cofilin, which increases the rate of dissociation of actin monomers 
from the pointed end of F-actin and severs F-actin (Bamburg, 1999; Chen et al., 2000; Sarmiere 
and Bamburg, 2004). The ability of ADF/cofilin to bind to F-actin is inhibited by 
phosphorylation on serine 3 by LIM kinase (LIMK) and by binding to phosphatidylinositol-
phosphates (Yonezawa et al., 1991; Agnew et al., 1995; Arber et al., 1998; Sarmiere and 
Bamburg, 2004). Dephosphorylation of ADF/cofilin by phosphatases such as 
calcium/calmodulin-dependent phosphatase 2B (calcineurin) and slingshot activates ADF/cofilin 
(Meberg et al., 1998; Niwa et al., 2002; Sarmiere and Bamburg, 2004). PI-3K can inactivate 
ADF/cofilin via its lipid kinase activity by activating ROCK, which in turn activates LIMK 
(Maekawa et al., 1999). LIMK then phosphorylates and deactivates ADF/cofilin. Another 
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pathway to inactivate ADF/cofilin may be through its protein kinase activity by activation of Rac 
and Cdc42, which in turn activate the protein kinase (PAK), which phosphorylates LIMK 
(Manser et al., 1994; Edwards et al., 1999). Taken together, inhibition of PI-3K may induce actin 
polymerization by inhibition of the pathways mentioned above. This proposal is supported by a 
recent study on chick retinal neurons, in which BDNF induces filopodial elongation by activation 
of ADF/cofilin through inhibition of ROCK (Gehler et al., 2004). In addition to mediating 
filopodial elongation induced by inhibition of PI-3K, ADF/cofilin may regulate NO-induced 
filopodial elongation as well. Because NO induces an increase in [Ca2+]i and dephosphorylation 
of ADF/cofilin can be caused by an increase in [Ca2+]i and the calcium/calmodulin-dependent 
phosphatase, calcineurin (Meberg et al., 1998), we can envision that by increasing [Ca2+]i, NO 
activates calcineurin, which dephosphorylates and activates ADF/cofilin, providing more actin 
monomers available for polymerization at the barbed end of F-actin. In summary, PI-3K and 
NO play an important role in regulating F-actin dynamics in growth cone filopodia during 
pathfinding. ABPs such as profilin, gelsolin and cofilin are the likely points of convergence 
of different signaling pathways and, therefore, modification of their activity will influence 
growth cone behavior (Fig. 5.1). 
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Figure 5.1: Possible PI-3K and NO signaling pathways regulating filopodial length.  
Activation of PI-3K by RTK leads to activation of Cdc42, Rac and ROCK, which in turn 
activates PAK and LIMK, respectively. Activation of PAK and LIMK, in turn, lead to the 
phosphorylation and subsequent inactivation of ADF/cofilin. PIP2 and PIP3, produced by PI-3K, 
inactivate capping proteins such as gelsolin and the actin monomer sequestering protein profilin. 
The activity of profilin can be enhanced via phosphorylation by PI-3K. An increase in [Ca2+]i by 
endogenous and exogenous NO activates calcineurin, which in turn dephosphorylates and 
activates ADF/cofilin. [Ca2+]i also activates gelsolin.  
PI-3K: phosphatidylinositol-3 kinase; RTK: receptor tyrosine kinase; ROCK: RhoA activated 
protein kinase; PIP2: phosphatidylinositol-biphosphates; PIP3: phosphatidylinositol-
triphosphates; LIMK: LIM kinase; [Ca2+]i: intracellular calcium concentration; ADF: actin 
depolymerizing factor.  
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Conclusions 
Taken together, the studies presented in this dissertation provide new insights into the 
signaling mechanisms that control growth cone dynamics.  
 
In Specific Aim 1 (Chapter 2), we demonstrated a role of PI-3K in regulating growth 
cone dynamics and motility. Inhibition of PI-3K induces both an increase in filopodial length and 
a decrease in the rate of neurite outgrowth. These effects were mediated by the lipid and protein 
kinase activities of PI-3K, resulting in the activation of Akt, ROCK and MEKK respectively. 
Filopodial elongation induced by inhibition of PI-3K is mediated by an increase in the time 
individual filopodia spend extending and by an increase in the rate at which filopodia extend. We 
also have demonstrated that filopodial elongation resulting from the inhibition of PI-3K is 
mediated by an increase in actin polymerization at the barbed end. Therefore, these results 
demonstrate that PI-3K and its downstream targets can regulate growth cone dynamics, which 
are known to be crucial for correct neuronal pathfinding in vivo. 
 
In Specific Aim 2 (Chapter 3), we have shown that physiological concentrations of NO 
can affect growth cone dynamics. NO release from a single cell induces a rapid increase in 
filopodial length. This effect on filopodial dynamics is reversible, mediated by the canonical 
target of NO, sGC, and limited to the stimulated growth cone. Cellular NO can have a 
physiological effect on filopodial dynamics at a distance of up to 100 µm. Therefore, these 
results demonstrate that physiological release of NO can affect growth cone morphology. 
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The proper functioning of the nervous system depends on the formation of correct 
connectivity during development. Misguidance or failure to wire correctly can lead to clinical 
disorders often related to cognitive and mental illness, or to neuromuscular dysfunction, which 
occurs in spinal muscular atrophy. A combination of clinical and cell culture studies have started 
to describe the molecules and mechanisms underlying these diseases. In vitro studies often allow a 
deeper understanding into the molecular and cellular mechanisms regulating many processes of 
neuronal development, such as neuronal survival, differentiation, motility, pathfinding and 
synaptogenesis, because they simplify the complexities that occur when studying these events in 
vivo. Our findings on how NO and PI-3K affect filopodial dynamics provide novel insight into the 
cellular mechanisms controlling growth cone motility in vitro, which is known to be critical for 
correct pathfinding and establishment of appropriate connectivity. Studies focusing on single 
molecules provide critical information on signaling pathways, but in vivo, multiple molecules and 
their signals interact with each other to govern a specific growth cone behavior. Therefore in the 
future, to better understand growth cone behavior in vivo, studies will need to focus on how growth 
cones integrate different signals, and on mechanisms involved in modulating growth cone 
responses to specific guidance cues. Follow up studies to the in vitro assay used here will need to 
test the role of identified molecules and second messengers affecting growth cone dynamics in 
vivo. This will allow for an understanding of their role in the development of the nervous system.  
In conclusion, these studies not only provide new information about signaling pathways 
and second messengers regulating growth cone dynamics, but also contribute to our 
understanding of the mechanistic basis of wiring defects associated with brain abnormalities. 
Most importantly, a better understanding of the cellular and molecular mechanisms regulating 
growth cone motility during the development of the nervous system may provide the foundation 
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for clinical approaches to enhance correct navigation and appropriate connectivity of neuronal 
circuitry to promote regeneration and repair following nerve injury and degeneration. 
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